×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Labcorp Holdings Inc.. (LH) NEW YORK STOCK EXCHANGE INC.

$207.38 0.88 (0.43%)

Market Cap: -

As of 06/20/24 04:00 PM EDT. Market closed.

(LH)

Labcorp Holdings Inc.. (LH)
NEW YORK STOCK EXCHANGE INC.

$207.38
0.88 (0.43%)

Market Cap: -

As of 06/20/24 04:00 PM EDT. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Industry
CEO Compensation (Base)
$1.18M
CEO Compensation (Total)
$12.26M
URL
Address
.
Sector
Industry
CEO Compensation (Base)
$1.18M
CEO Compensation (Total)
$12.26M
URL
Address
.
PRICE CHART FOR LABCORP HOLDINGS INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$206.05
Previous Close
$206.50
Days Range
$201.10 - $206.76
52 week range
$191.97 - $213.52
Volume
974,385
Avg. Volume (30 days)
728,920
Market Cap
-
Dividend Yield
0.35%
P/E
-
Shares Outstanding
0
Open
$206.05
Previous Close
$206.50
Days Range
$201.10 - $206.76
52 week range
$191.97 - $213.52
Volume
974,385
Avg. Volume (30 days)
728,920
Market Cap
-
Dividend Yield
0.35%
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR LABCORP HOLDINGS INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR LABCORP HOLDINGS INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
van der Vaart Sandra DEVP, Chief Legal OfficerMay 14, 2024 Sale$210.832,000421,6555,837May 16, 2024, 08:02 AM
ANDERSON KERRII BDirectorApr 30, 2024 Sale$204.1325051,03415,972May 02, 2024, 04:29 PM
ANDERSON KERRII BDirectorMay 02, 2024 Sale$200.1025050,02515,722May 02, 2024, 04:29 PM
EISENBERG GLENN AChief Financial Officer, EVPApr 30, 2024 Option Exercise$201.374,496905,35946,289May 02, 2024, 12:45 PM
Wilkinson Peter JSVP, Chief Accounting OfficerApr 29, 2024 Sale$204.332,439498,3582,087May 01, 2024, 06:29 PM
EISENBERG GLENN AChief Financial Officer, EVPApr 15, 2024 Option Exercise$203.324,496914,12740,556Apr 17, 2024, 08:25 AM
Schroeder Mark SEVP, Pres Diagnostics & COOApr 01, 2024 Sale$217.296,4771,407,3875,036Apr 03, 2024, 08:35 AM
Summy Amy B.EVP, Chief Marketing OfficerApr 01, 2024 Sale$217.293,500760,5153,975Apr 03, 2024, 08:34 AM
Bailey Megan D.EVP, Chief Strategy OfficerApr 01, 2024 Option Exercise$216.356914,928436Apr 03, 2024, 08:31 AM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 27, 2024 Option Exercise$216.572,605564,16511,190Mar 29, 2024, 05:54 PM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 28, 2024 Sale$216.743,553770,0777,637Mar 29, 2024, 05:54 PM
Caveney Brian JEVP, Pres of ED, CMO & CSOMar 27, 2024 Option Exercise$216.575,0611,096,06127,881Mar 29, 2024, 05:42 PM
Schroeder Mark SEVP, Pres Diagnostics & COOMar 27, 2024 Option Exercise$216.575,0791,099,95911,513Mar 29, 2024, 05:32 PM
Schechter Adam HPresident and CEOMar 27, 2024 Option Exercise$216.5731,7996,886,71093,630Mar 29, 2024, 05:23 PM
DiVincenzo Jonathan P.EVP, Pres, Central Labs & IntlMar 27, 2024 Option Exercise$216.57952206,1755,461Mar 29, 2024, 05:15 PM
Wilkinson Peter JSVP, Chief Accounting OfficerMar 27, 2024 Option Exercise$216.57894193,6144,526Mar 29, 2024, 05:07 PM
Summy Amy B.EVP, Chief Marketing OfficerMar 27, 2024 Option Exercise$216.572,162468,2247,475Mar 29, 2024, 04:59 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 27, 2024 Option Exercise$216.578,8051,906,89934,823Mar 29, 2024, 04:50 PM
BERBERIAN LANCEEVP, CIO & CTOMar 27, 2024 Option Exercise$216.573,299714,46428,014Mar 29, 2024, 04:32 PM
Schroeder Mark SEVP, Pres Diagnostics & COOMar 07, 2024 Option Exercise$117.092,119248,11410,084Mar 11, 2024, 08:59 AM
Schroeder Mark SEVP, Pres Diagnostics & COOMar 07, 2024 Sale$218.455,0481,102,7365,036Mar 11, 2024, 08:59 AM
Summy Amy B.EVP, Chief Marketing OfficerMar 07, 2024 Sale$218.4522749,5883,859Mar 11, 2024, 08:56 AM
EISENBERG GLENN AChief Financial Officer, EVPFeb 21, 2024 Option Exercise$163.6314,0542,299,65658,099Feb 22, 2024, 03:05 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 21, 2024 Sale$215.9734,5047,451,86739,720Feb 22, 2024, 03:05 PM
DiVincenzo Jonathan P.EVP, Pres, Central Labs & IntlFeb 21, 2024 Sale$215.49500107,7453,401Feb 22, 2024, 03:04 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 13, 2024 Sale$226.4523753,6697,637Feb 15, 2024, 08:32 AM
Schechter Adam HPresident & CEOFeb 12, 2024 Option Exercise$227.451,231279,99152,994Feb 13, 2024, 12:17 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2024 Option Exercise$227.4521548,90244,045Feb 13, 2024, 12:16 PM
DiVincenzo Jonathan P.EVP, Pres, Central Labs & IntlFeb 12, 2024 Option Exercise$227.455913,4203,901Feb 13, 2024, 12:15 PM
Caveney Brian JEVP, Pres of ED, CMO & CSOFeb 12, 2024 Option Exercise$227.4513731,16121,386Feb 13, 2024, 12:13 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 12, 2024 Option Exercise$227.458719,78823,616Feb 13, 2024, 12:12 PM
Schroeder Mark SEVP, Pres Diagnostics & COOFeb 12, 2024 Option Exercise$227.4512628,6597,965Feb 13, 2024, 12:11 PM
Summy Amy B.EVP, Chief Marketing OfficerFeb 12, 2024 Option Exercise$227.456615,0124,086Feb 13, 2024, 12:10 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 12, 2024 Option Exercise$227.458719,7887,874Feb 13, 2024, 12:09 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 12, 2024 Option Exercise$227.45439,7802,341Feb 13, 2024, 12:08 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 08, 2024 Sale$222.0625957,5147,637Feb 09, 2024, 12:19 PM
Schechter Adam HPresident & CEOFeb 07, 2024 Option Exercise$223.711,149257,04351,261Feb 08, 2024, 03:27 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 07, 2024 Option Exercise$223.7123652,79643,453Feb 08, 2024, 03:26 PM
DiVincenzo Jonathan P.EVP, Pres, Central Labs & IntlFeb 07, 2024 Option Exercise$223.7111926,6213,759Feb 08, 2024, 03:25 PM
Caveney Brian JEVP, Pres of ED, CMO & CSOFeb 07, 2024 Option Exercise$223.7120445,63721,051Feb 08, 2024, 03:22 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 07, 2024 Option Exercise$223.719421,02923,379Feb 08, 2024, 03:21 PM
Bailey Megan D.EVP, Chief Strategy OfficerFeb 07, 2024 Option Exercise$223.7111325,279300Feb 08, 2024, 03:20 PM
GRAHAM ANITA ZEVP, CHROFeb 07, 2024 Option Exercise$223.7110723,937292Feb 08, 2024, 03:19 PM
Schroeder Mark SEVP, Pres Diagnostics & COOFeb 07, 2024 Option Exercise$223.7118240,7157,619Feb 08, 2024, 03:18 PM
Summy Amy B.EVP, Chief Marketing OfficerFeb 07, 2024 Option Exercise$223.717316,3313,951Feb 08, 2024, 03:17 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 07, 2024 Option Exercise$223.719421,0297,896Feb 08, 2024, 03:10 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 07, 2024 Option Exercise$223.714610,2912,261Feb 08, 2024, 03:09 PM
BELINGARD JEAN-LUCDirectorFeb 07, 2024 Option Exercise$223.719521,25217,781Feb 08, 2024, 12:43 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 02, 2024 Option Exercise$221.54459,9692,173Feb 06, 2024, 04:32 PM
Summy Amy B.EVP, Chief Marketing OfficerFeb 02, 2024 Option Exercise$221.548017,7233,800Feb 06, 2024, 04:23 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 02, 2024 Option Exercise$221.548919,71723,120Feb 06, 2024, 04:04 PM
Caveney Brian JEVP, Pres of ED, CMO & CSOFeb 02, 2024 Option Exercise$221.5416636,77620,626Feb 06, 2024, 04:01 PM
Schechter Adam HPresident & CEOFeb 02, 2024 Option Exercise$221.54822182,10649,160Feb 06, 2024, 03:58 PM
DiVincenzo Jonathan P.EVP, Pres, Central Labs & IntlFeb 02, 2024 Option Exercise$221.548518,8313,516Feb 06, 2024, 03:56 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 02, 2024 Option Exercise$221.5422850,51142,804Feb 06, 2024, 03:55 PM
Schroeder Mark SEVP, Pres Diagnostics & COOFeb 02, 2024 Option Exercise$221.5413229,2437,121Feb 06, 2024, 03:52 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 02, 2024 Option Exercise$221.547115,7297,830Feb 06, 2024, 03:47 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 05, 2024 Sale$220.5719342,5707,637Feb 06, 2024, 03:47 PM
DiVincenzo Jonathan P.EVP, Pres, Central Labs & IntlDec 15, 2023 Option Exercise$219.50194,1713,355Dec 19, 2023, 08:34 AM
Wilkinson Peter JSVP, Chief Accounting OfficerNov 16, 2023 Sale$210.711,384291,6272,087Nov 20, 2023, 12:23 PM
ANDERSON KERRII BDirectorAug 08, 2023 Sale$211.575,0001,057,83215,275Aug 10, 2023, 08:55 AM
Wilkinson Peter JSVP, Chief Accounting OfficerAug 01, 2023 Option Exercise$213.61173,6313,471Aug 03, 2023, 05:05 PM
van der Vaart Sandra DEVP, Chief Legal OfficerJun 29, 2023 Sale$240.0021250,8807,605Jul 03, 2023, 11:52 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentMay 19, 2023 Option Exercise$182.514,300784,79317,246May 23, 2023, 08:06 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentMay 19, 2023 Sale$216.914,300932,70712,946May 23, 2023, 08:06 AM
Schroeder Mark SEVP, Pres Diagnostics & COOMay 18, 2023 Option Exercise$130.601,500195,9008,187May 22, 2023, 03:08 PM
Schroeder Mark SEVP, Pres Diagnostics & COOMay 18, 2023 Sale$216.771,500325,1556,687May 22, 2023, 03:08 PM
Schechter Adam HPresident & CEOMar 30, 2023 Option Exercise$224.7018,6464,189,75646,888Apr 03, 2023, 10:14 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentMar 30, 2023 Option Exercise$224.702,886648,48412,946Apr 03, 2023, 10:13 AM
EISENBERG GLENN AChief Financial Officer, EVPMar 30, 2023 Option Exercise$224.705,1791,163,72142,176Apr 03, 2023, 10:11 AM
Caveney Brian JEVP, President of DiagnosticsMar 30, 2023 Option Exercise$224.702,990671,85320,186Apr 03, 2023, 10:09 AM
BERBERIAN LANCEEVP, CIO & CTOMar 30, 2023 Option Exercise$224.701,799404,23522,878Apr 03, 2023, 10:07 AM
Schroeder Mark SEVP, President-Diagnostics LabMar 30, 2023 Option Exercise$224.702,866643,99010,584Apr 03, 2023, 10:05 AM
Schroeder Mark SEVP, President-Diagnostics LabMar 31, 2023 Sale$225.813,897879,9826,687Apr 03, 2023, 10:05 AM
Seltz Judith CEVP, CHROMar 30, 2023 Option Exercise$224.701,164261,5514,182Apr 03, 2023, 10:03 AM
Summy Amy B.EVP, Chief Marketing OfficerMar 30, 2023 Option Exercise$224.701,269285,1443,634Apr 03, 2023, 09:56 AM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 30, 2023 Option Exercise$224.701,371308,0647,791Apr 03, 2023, 09:50 AM
Wilkinson Peter JSVP, Chief Accounting OfficerMar 30, 2023 Option Exercise$224.70526118,1923,432Apr 03, 2023, 09:49 AM
Summy Amy B.EVP, Chief Marketing OfficerMar 02, 2023 Option Exercise$239.4637489,5581,669Mar 06, 2023, 08:04 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 21, 2023 Option Exercise$182.513,000547,53017,069Feb 23, 2023, 09:54 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 21, 2023 Sale$250.588,0002,004,6759,069Feb 23, 2023, 09:54 AM
Schroeder Mark SEVP, President-Diagnostics LabFeb 14, 2023 Sale$247.6330976,5186,687Feb 16, 2023, 12:51 PM
BELINGARD JEAN-LUCDirectorFeb 13, 2023 Option Exercise$248.137518,61016,929Feb 14, 2023, 03:25 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 13, 2023 Option Exercise$248.138521,09120,168Feb 14, 2023, 03:01 PM
Caveney Brian JEVP, President of DiagnosticsFeb 13, 2023 Option Exercise$248.1312430,76816,413Feb 14, 2023, 02:59 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 13, 2023 Option Exercise$248.1314235,23414,069Feb 14, 2023, 02:57 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 13, 2023 Option Exercise$248.1319548,38535,640Feb 14, 2023, 02:56 PM
Schechter Adam HPresident & CEOFeb 13, 2023 Option Exercise$248.131,170290,31223,181Feb 14, 2023, 02:55 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 13, 2023 Option Exercise$248.1311428,2876,996Feb 14, 2023, 02:54 PM
Seltz Judith CEVP, CHROFeb 13, 2023 Option Exercise$248.136917,1211,965Feb 14, 2023, 02:52 PM
Summy Amy B.EVP, Chief Marketing OfficerFeb 13, 2023 Option Exercise$248.135413,399703Feb 14, 2023, 02:51 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 13, 2023 Option Exercise$248.137819,3545,553Feb 14, 2023, 02:50 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 13, 2023 Option Exercise$248.13389,4292,160Feb 14, 2023, 02:49 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 07, 2023 Sale$243.0121953,2195,341Feb 09, 2023, 09:27 AM
Schroeder Mark SEVP, President-Diagnostics LabFeb 07, 2023 Sale$243.0140999,3916,687Feb 09, 2023, 09:04 AM
Schechter Adam HPresident & CEOFeb 06, 2023 Option Exercise$244.501,368334,47621,695Feb 07, 2023, 02:55 PM
Caveney Brian JEVP, President of DiagnosticsFeb 06, 2023 Option Exercise$244.5016440,09816,114Feb 07, 2023, 02:54 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 06, 2023 Option Exercise$244.5010826,40619,963Feb 07, 2023, 02:53 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 06, 2023 Option Exercise$244.5026163,81535,112Feb 07, 2023, 02:52 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 06, 2023 Option Exercise$244.5016440,09813,728Feb 07, 2023, 02:51 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 06, 2023 Option Exercise$244.5015136,9207,096Feb 07, 2023, 02:50 PM
Seltz Judith CEVP, CHROFeb 06, 2023 Option Exercise$244.508420,5381,798Feb 07, 2023, 02:48 PM
Summy Amy B.EVP, Chief Marketing OfficerFeb 06, 2023 Option Exercise$244.508320,294577Feb 07, 2023, 02:47 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 06, 2023 Option Exercise$244.508119,8055,560Feb 07, 2023, 02:47 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 06, 2023 Option Exercise$244.505212,7142,088Feb 07, 2023, 02:45 PM
Seltz Judith CEVP, CHROFeb 02, 2023 Option Exercise$254.997719,6341,602Feb 06, 2023, 04:00 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 02, 2023 Option Exercise$254.996416,3195,514Feb 06, 2023, 03:56 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 03, 2023 Sale$253.9017343,9255,341Feb 06, 2023, 03:56 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 02, 2023 Option Exercise$254.994110,4551,990Feb 06, 2023, 03:55 PM
Summy Amy B.EVP, Chief Marketing OfficerFeb 02, 2023 Option Exercise$254.997719,634393Feb 06, 2023, 03:54 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 02, 2023 Option Exercise$254.9911930,3447,011Feb 06, 2023, 03:51 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 03, 2023 Sale$253.9032482,2646,687Feb 06, 2023, 03:51 PM
Schechter Adam HPresident & CEOFeb 02, 2023 Option Exercise$254.99805205,26719,556Feb 06, 2023, 03:49 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 02, 2023 Option Exercise$254.9914135,95413,332Feb 06, 2023, 03:45 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 02, 2023 Option Exercise$254.9920652,52834,403Feb 06, 2023, 03:43 PM
Caveney Brian JEVP, President of DiagnosticsFeb 02, 2023 Option Exercise$254.9914436,71915,718Feb 06, 2023, 03:41 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 02, 2023 Option Exercise$254.9910226,00919,697Feb 06, 2023, 03:40 PM
Schroeder Mark SEVP, President-Diagnostics LabNov 08, 2022 Sale$232.671,116259,6606,687Nov 10, 2022, 08:40 AM
Schroeder Mark SEVP, President-Diagnostics LabNov 07, 2022 Option Exercise$233.77894208,9907,803Nov 08, 2022, 04:27 PM
Caveney Brian JEVP, President of DiagnosticsNov 07, 2022 Option Exercise$233.77894208,99015,398Nov 08, 2022, 04:20 PM
EISENBERG GLENN AChief Financial Officer, EVPNov 01, 2022 Option Exercise$222.565,3481,190,25133,842Nov 03, 2022, 05:04 PM
Schechter Adam HPresident & CEONov 01, 2022 Option Exercise$222.56893198,74617,588Nov 03, 2022, 05:01 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentNov 01, 2022 Option Exercise$222.56892198,52413,030Nov 03, 2022, 05:00 PM
EISENBERG GLENN AChief Financial Officer, EVPSep 26, 2022 Sale$210.6225,0005,265,58146,531Sep 28, 2022, 09:12 AM
Caveney Brian JEVP, President of DiagnosticsSep 07, 2022 Buy$231.204410,17314,282Sep 13, 2022, 11:39 AM
EISENBERG GLENN AChief Financial Officer, EVPAug 03, 2022 Option Exercise$147.1232,1004,722,54384,258Aug 05, 2022, 09:52 AM
EISENBERG GLENN AChief Financial Officer, EVPAug 03, 2022 Sale$253.9432,1008,151,45072,996Aug 05, 2022, 09:52 AM
Wilkinson Peter JSVP, Chief Accounting OfficerAug 01, 2022 Option Exercise$257.94235,9331,914Aug 03, 2022, 11:54 AM
Wilkinson Peter JSVP, Chief Accounting OfficerAug 01, 2022 Option Exercise$146.59767112,4352,654Aug 03, 2022, 11:54 AM
Wilkinson Peter JSVP, Chief Accounting OfficerAug 01, 2022 Sale$258.402,576665,6341,897Aug 03, 2022, 11:54 AM
Caveney Brian JEVP, President of DiagnosticsJun 07, 2022 Buy$242.194210,17214,172Jun 14, 2022, 08:46 AM
Schroeder Mark SEVP, President-Diagnostics LabMar 29, 2022 Sale$277.112,356652,8716,605Mar 31, 2022, 10:24 AM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 29, 2022 Sale$277.112,449678,6425,287Mar 31, 2022, 10:20 AM
BERBERIAN LANCEEVP, CIO & CTOMar 28, 2022 Option Exercise$276.422,360652,35119,502Mar 29, 2022, 12:09 PM
Caveney Brian JEVP, President of DiagnosticsMar 28, 2022 Option Exercise$276.421,883520,49914,130Mar 29, 2022, 12:07 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 28, 2022 Option Exercise$276.426,2861,737,57652,158Mar 29, 2022, 12:05 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentMar 28, 2022 Option Exercise$276.421,648455,54011,915Mar 29, 2022, 12:04 PM
Schroeder Mark SEVP, President-Diagnostics LabMar 28, 2022 Option Exercise$276.421,885521,0528,961Mar 29, 2022, 12:03 PM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 28, 2022 Option Exercise$276.421,792495,3457,736Mar 29, 2022, 12:02 PM
Wilkinson Peter JSVP, Chief Accounting OfficerMar 28, 2022 Option Exercise$276.42915252,9243,696Mar 29, 2022, 12:00 PM
Williams R SandersDirectorMar 25, 2022 Sale$272.98572156,1456,431Mar 29, 2022, 09:46 AM
Summy Amy B.EVP, Chief Marketing OfficerMar 10, 2022 Sale$262.2124965,290250Mar 14, 2022, 04:36 PM
NEUPERT PETER MDirectorFeb 16, 2022 Buy$263.663,500922,81510,254Feb 18, 2022, 08:46 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 15, 2022 Sale$273.9820756,7146,605Feb 17, 2022, 03:05 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 15, 2022 Sale$273.9820756,7145,287Feb 17, 2022, 03:03 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 14, 2022 Option Exercise$272.6826171,1691,989Feb 15, 2022, 04:51 PM
Caveney Brian JEVP, President of DiagnosticsFeb 14, 2022 Option Exercise$272.68778212,14512,466Feb 15, 2022, 04:48 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 14, 2022 Option Exercise$272.6827775,53244,300Feb 15, 2022, 04:43 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 14, 2022 Option Exercise$272.6810829,4499,856Feb 15, 2022, 04:42 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 14, 2022 Option Exercise$272.68799217,87116,657Feb 15, 2022, 04:40 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 14, 2022 Option Exercise$272.687720,9966,812Feb 15, 2022, 04:38 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 14, 2022 Option Exercise$272.687720,9965,494Feb 15, 2022, 04:37 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 04, 2022 Option Exercise$277.4810930,24514,643Feb 08, 2022, 11:19 AM
Caveney Brian JEVP, President of DiagnosticsFeb 04, 2022 Option Exercise$277.4816545,7849,912Feb 08, 2022, 11:18 AM
EISENBERG GLENN AChief Financial Officer, EVPFeb 04, 2022 Option Exercise$277.4828679,35943,637Feb 08, 2022, 11:16 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 04, 2022 Option Exercise$277.4816545,7849,647Feb 08, 2022, 11:13 AM
Schechter Adam HPresident & CEOFeb 04, 2022 Option Exercise$277.481,412391,80216,474Feb 08, 2022, 11:10 AM
Schroeder Mark SEVP, President-Diagnostics LabFeb 04, 2022 Option Exercise$277.4815242,1776,809Feb 08, 2022, 11:08 AM
Schroeder Mark SEVP, President-Diagnostics LabFeb 07, 2022 Sale$277.3820456,5866,605Feb 08, 2022, 11:08 AM
Seltz Judith CEVP, CHROFeb 04, 2022 Option Exercise$277.488523,5861,377Feb 08, 2022, 11:06 AM
Summy Amy B.EVP, Chief Marketing OfficerFeb 04, 2022 Option Exercise$277.488323,031499Feb 08, 2022, 11:03 AM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 04, 2022 Option Exercise$277.488222,7535,505Feb 08, 2022, 11:01 AM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 07, 2022 Sale$277.3821860,4695,287Feb 08, 2022, 11:01 AM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 04, 2022 Option Exercise$277.485314,7061,183Feb 08, 2022, 11:00 AM
Schroeder Mark SEVP, President-Diagnostics LabFeb 02, 2022 Option Exercise$273.1812133,0556,562Feb 04, 2022, 12:15 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 03, 2022 Sale$271.8116143,7616,401Feb 04, 2022, 12:15 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 02, 2022 Option Exercise$273.186417,4845,459Feb 04, 2022, 12:14 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 03, 2022 Sale$271.8117246,7515,287Feb 04, 2022, 12:14 PM
Summy Amy B.EVP, Chief Marketing OfficerFeb 02, 2022 Option Exercise$273.187721,035315Feb 04, 2022, 09:45 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 02, 2022 Option Exercise$273.1814439,3389,252Feb 04, 2022, 09:44 AM
Seltz Judith CEVP, CHROFeb 02, 2022 Option Exercise$273.187620,7621,182Feb 04, 2022, 09:43 AM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 02, 2022 Option Exercise$273.184111,2001,086Feb 04, 2022, 09:42 AM
Caveney Brian JEVP, President of DiagnosticsFeb 02, 2022 Option Exercise$273.1814740,1579,517Feb 04, 2022, 09:37 AM
Schechter Adam HPresident & CEOFeb 02, 2022 Option Exercise$273.18803219,36414,379Feb 04, 2022, 09:36 AM
EISENBERG GLENN AChief Financial Officer, EVPFeb 02, 2022 Option Exercise$273.1823664,47042,953Feb 04, 2022, 09:34 AM
BERBERIAN LANCEEVP, CIO & CTOFeb 02, 2022 Option Exercise$273.1810328,13814,379Feb 04, 2022, 09:33 AM
BELINGARD JEAN-LUCDirectorFeb 02, 2022 Option Exercise$273.187821,30816,262Feb 04, 2022, 09:00 AM
Gilliland Dwight GaryDirectorDec 15, 2021 Sale$302.26500151,1286,395Dec 17, 2021, 10:36 AM
Caveney Brian JEVP, President of DiagnosticsNov 05, 2021 Option Exercise$274.84899247,0819,182Nov 09, 2021, 02:49 PM
Schroeder Mark SEVP, President-Diagnostics LabNov 05, 2021 Option Exercise$274.84899247,0816,240Nov 09, 2021, 02:46 PM
Schechter Adam HPresident & CEONov 01, 2021 Option Exercise$288.78886255,85912,409Nov 03, 2021, 11:51 AM
EISENBERG GLENN AChief Financial Officer, EVPNov 01, 2021 Option Exercise$288.784,0341,164,93942,423Nov 03, 2021, 11:49 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentNov 01, 2021 Option Exercise$288.78898259,3248,953Nov 03, 2021, 11:47 AM
van der Vaart Sandra DEVP, Chief Legal OfficerSep 15, 2021 Option Exercise$84.864,500381,8709,765Sep 17, 2021, 12:20 PM
van der Vaart Sandra DEVP, Chief Legal OfficerSep 15, 2021 Sale$296.784,5001,335,5105,265Sep 17, 2021, 12:20 PM
Wilkinson Peter JSVP, Chief Accounting OfficerAug 02, 2021 Option Exercise$297.61154,4641,011Aug 03, 2021, 04:16 PM
van der Vaart Sandra DEVP, Chief Legal OfficerJun 07, 2021 Option Exercise$84.864,500381,8709,737Jun 09, 2021, 02:03 PM
van der Vaart Sandra DEVP, Chief Legal OfficerJun 07, 2021 Sale$266.564,5001,199,5205,237Jun 09, 2021, 02:03 PM
BELINGARD JEAN-LUCDirectorMay 03, 2021 Option Exercise$98.492,600256,07418,169May 05, 2021, 10:48 AM
BELINGARD JEAN-LUCDirectorMay 03, 2021 Sale$269.152,600699,80315,569May 05, 2021, 10:48 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentApr 03, 2021 Option Exercise$252.67452114,20710,344Apr 06, 2021, 12:18 PM
Schroeder Mark SEVP, President-Diagnostics LabMar 30, 2021 Sale$251.88667168,0045,006Apr 01, 2021, 08:32 AM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 30, 2021 Sale$251.88812204,5275,237Apr 01, 2021, 08:32 AM
EISENBERG GLENN AChief Financial Officer, EVPMar 27, 2021 Option Exercise$251.583,595904,43037,433Mar 30, 2021, 06:46 PM
BERBERIAN LANCEEVP, CIO & CTOMar 27, 2021 Option Exercise$251.581,079271,45514,186Mar 30, 2021, 06:45 PM
Caveney Brian JEVP, President of DiagnosticsMar 27, 2021 Option Exercise$251.581,079271,4558,001Mar 30, 2021, 06:43 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentMar 27, 2021 Option Exercise$251.58790198,7489,786Mar 30, 2021, 06:42 PM
Schroeder Mark SEVP, President-Diagnostics LabMar 27, 2021 Option Exercise$251.581,079271,4555,673Mar 30, 2021, 06:41 PM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 27, 2021 Option Exercise$251.58687172,8356,049Mar 30, 2021, 06:40 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 12, 2021 Option Exercise$238.2626362,6621,127Feb 19, 2021, 02:17 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 18, 2021 Option Exercise$157.092,166340,2512,660Feb 19, 2021, 02:17 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 18, 2021 Sale$241.512,317559,590343Feb 19, 2021, 02:17 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 12, 2021 Option Exercise$238.2615837,6454,634Feb 17, 2021, 04:28 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 16, 2021 Sale$236.5520849,2024,531Feb 17, 2021, 04:28 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 12, 2021 Option Exercise$238.2614233,8334,527Feb 17, 2021, 04:27 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 16, 2021 Sale$237.0618844,5674,424Feb 17, 2021, 04:27 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 12, 2021 Option Exercise$238.2618042,8878,472Feb 17, 2021, 04:25 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2021 Option Exercise$238.26512121,98932,986Feb 17, 2021, 04:23 PM
Caveney Brian JEVP, President of DiagnosticsFeb 12, 2021 Option Exercise$238.26854203,4746,667Feb 17, 2021, 04:22 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 12, 2021 Option Exercise$238.26873208,00112,852Feb 17, 2021, 04:21 PM
Schechter Adam HPresident & CEOFeb 04, 2021 Option Exercise$223.781,028230,04611,288Feb 08, 2021, 03:48 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 04, 2021 Option Exercise$223.785311,860523Feb 08, 2021, 03:46 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 04, 2021 Option Exercise$223.788318,5744,328Feb 08, 2021, 03:43 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 05, 2021 Sale$225.8510924,6184,219Feb 08, 2021, 03:43 PM
Summy Amy B.EVP, Chief Marketing OfficerFeb 04, 2021 Option Exercise$223.789421,035172Feb 08, 2021, 03:42 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 04, 2021 Option Exercise$223.7815434,4624,355Feb 08, 2021, 03:40 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 05, 2021 Sale$225.8520345,8484,152Feb 08, 2021, 03:40 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 04, 2021 Option Exercise$223.7818741,8478,071Feb 08, 2021, 03:39 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 04, 2021 Option Exercise$223.7830668,47731,778Feb 08, 2021, 03:36 PM
Caveney Brian JEVP, President of DiagnosticsFeb 04, 2021 Option Exercise$223.7819042,5184,651Feb 08, 2021, 03:35 PM
BERBERIAN LANCEEVP, CIO & CTOFeb 04, 2021 Option Exercise$223.7813129,31510,785Feb 08, 2021, 03:34 PM
Seltz Judith CEVP, CHROFeb 04, 2021 Option Exercise$223.789621,483915Feb 08, 2021, 03:33 PM
BELINGARD JEAN-LUCDirectorFeb 04, 2021 Option Exercise$223.789922,15415,569Feb 08, 2021, 03:14 PM
Williams R SandersDirectorJan 26, 2021 Option Exercise$98.491,300128,0375,246Jan 28, 2021, 12:11 PM
Schroeder Mark SEVP, President-Diagnostics LabNov 06, 2020 Sale$214.59588126,1793,949Nov 10, 2020, 10:48 AM
Caveney Brian JEVP, President of DiagnosticsNov 05, 2020 Option Exercise$214.42886189,9764,221Nov 09, 2020, 09:21 AM
Schroeder Mark SEVP, President-Diagnostics LabNov 05, 2020 Option Exercise$214.42835179,0414,537Nov 09, 2020, 09:19 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentNov 04, 2020 Sale$214.141,500321,2047,698Nov 06, 2020, 09:06 AM
EISENBERG GLENN AChief Financial Officer, EVPNov 02, 2020 Option Exercise$207.234,034835,96631,114Nov 04, 2020, 05:47 PM
Schechter Adam HPresident & CEONov 02, 2020 Option Exercise$207.23885183,3998,810Nov 04, 2020, 05:43 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentNov 02, 2020 Option Exercise$207.23895185,4719,198Nov 04, 2020, 05:40 PM
Caveney Brian JEVP, President of DiagnosticsSep 25, 2020 Option Exercise$180.9928952,3063,097Sep 29, 2020, 01:42 PM
Williams R SandersDirectorJul 08, 2020 Option Exercise$98.491,300128,0376,395Jul 10, 2020, 04:25 PM
Williams R SandersDirectorJul 08, 2020 Sale$173.121,300225,0565,095Jul 10, 2020, 04:25 PM
van der Vaart Sandra DEVP, Chief Legal OfficerJul 02, 2020 Sale$170.0043573,9504,044Jul 07, 2020, 09:38 AM
van der Vaart Sandra DEVP, Chief Legal OfficerJun 24, 2020 Sale$160.33872139,8084,915Jun 26, 2020, 10:06 AM
KING DAVID PDirectorMay 05, 2020 Sale$160.0031,2505,000,000312,554May 07, 2020, 12:05 PM
Seltz Judith CEVP, CHROMar 10, 2020 Buy$168.5633055,625580May 04, 2020, 10:18 AM
Seltz Judith CEVP, CHROFeb 28, 2020 Buy$174.9425043,735250May 04, 2020, 10:18 AM
Kirchgraber Paul RCEO, Covance Drug DevelopmentApr 03, 2020 Option Exercise$113.3137242,1518,087Apr 07, 2020, 04:21 PM
KING DAVID PDirectorMar 30, 2020 Option Exercise$131.9524,5833,243,727343,804Apr 01, 2020, 02:40 PM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 30, 2020 Option Exercise$131.951,106145,9375,351Apr 01, 2020, 02:39 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 30, 2020 Option Exercise$131.955,787763,59526,124Apr 01, 2020, 02:33 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentMar 30, 2020 Option Exercise$131.951,014133,7977,449Apr 01, 2020, 02:29 PM
Schroeder Mark SEVP, President-Diagnostics LabMar 30, 2020 Option Exercise$131.951,153152,1383,213Apr 01, 2020, 02:28 PM
BERBERIAN LANCEEVP, CIO & CTOMar 30, 2020 Option Exercise$131.951,695223,65510,543Apr 01, 2020, 02:23 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 21, 2020 Sale$189.6529756,326297Feb 25, 2020, 12:59 PM
BELINGARD JEAN-LUCDirectorFeb 19, 2020 Option Exercise$77.193,100239,28941,161Feb 21, 2020, 03:52 PM
BELINGARD JEAN-LUCDirectorFeb 19, 2020 Sale$189.7626,4795,024,76114,682Feb 21, 2020, 03:52 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2020 Option Exercise$187.5151296,00518,966Feb 14, 2020, 05:32 PM
van der Vaart Sandra DSVP, Global General CounselFeb 12, 2020 Option Exercise$187.5115829,6272,944Feb 14, 2020, 05:11 PM
van der Vaart Sandra DSVP, Global General CounselFeb 13, 2020 Sale$188.4920839,2062,839Feb 14, 2020, 05:11 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 12, 2020 Option Exercise$187.5114226,626674Feb 14, 2020, 05:07 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 13, 2020 Sale$188.4918835,436589Feb 14, 2020, 05:07 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 12, 2020 Option Exercise$187.51872163,5098,358Feb 14, 2020, 04:11 PM
Caveney Brian JEVP, President of DiagnosticsFeb 12, 2020 Option Exercise$187.51866162,3842,326Feb 14, 2020, 03:51 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 12, 2020 Option Exercise$187.5127251,003594Feb 14, 2020, 03:50 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 12, 2020 Option Exercise$187.5115929,8145,061Feb 14, 2020, 03:48 PM
KING DAVID PDirectorFeb 12, 2020 Option Exercise$187.513,280615,033313,392Feb 14, 2020, 03:42 PM
BELINGARD JEAN-LUCDirectorFeb 12, 2020 Option Exercise$187.5112323,06438,061Feb 14, 2020, 03:30 PM
Williams R SandersDirectorFeb 13, 2020 Sale$188.491,227231,2775,095Feb 14, 2020, 03:08 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 07, 2020 Option Exercise$182.338214,951408Feb 11, 2020, 01:47 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 10, 2020 Sale$181.9910819,655300Feb 11, 2020, 01:47 PM
van der Vaart Sandra DSVP, Global General CounselFeb 07, 2020 Option Exercise$182.3310118,4152,662Feb 11, 2020, 01:45 PM
van der Vaart Sandra DSVP, Global General CounselFeb 10, 2020 Sale$181.9913324,2052,529Feb 11, 2020, 01:45 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentFeb 07, 2020 Option Exercise$182.3310318,7804,641Feb 11, 2020, 01:43 PM
KING DAVID PDirectorFeb 07, 2020 Option Exercise$182.331,252228,277308,923Feb 11, 2020, 01:42 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 07, 2020 Option Exercise$182.3329553,78717,758Feb 11, 2020, 01:39 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 07, 2020 Option Exercise$182.3310318,7806,291Feb 11, 2020, 01:38 PM
BELINGARD JEAN-LUCDirectorDec 04, 2019 Option Exercise$171.8232756,18536,957Dec 06, 2019, 03:07 PM
KING DAVID PPresident & CEOOct 28, 2019 Sale$165.4030,1774,991,216328,676Oct 30, 2019, 05:25 PM
ANDERSON KERRII BDirectorSep 23, 2019 Option Exercise$98.492,600256,07420,533Sep 25, 2019, 01:40 PM
ANDERSON KERRII BDirectorSep 23, 2019 Sale$171.852,600446,81017,933Sep 25, 2019, 01:40 PM
Uthgenannt Lisa JChief Human Resources OfficerSep 04, 2019 Option Exercise$130.602,466322,0607,126Sep 06, 2019, 09:54 AM
Uthgenannt Lisa JChief Human Resources OfficerSep 04, 2019 Sale$168.592,466415,7434,660Sep 06, 2019, 09:54 AM
BERBERIAN LANCESVP, Chief Information OfficerAug 30, 2019 Sale$169.805,9021,002,1716,097Sep 04, 2019, 09:04 AM
Williams R SandersDirectorAug 05, 2019 Sale$162.9150081,4556,886Aug 07, 2019, 11:40 AM
EISENBERG GLENN AChief Financial Officer, EVPJul 08, 2019 Sale$176.755,563983,26017,059Jul 10, 2019, 09:03 AM
van der Vaart Sandra DSVP, Global General CounselJul 08, 2019 Sale$176.752,328411,4742,328Jul 10, 2019, 09:02 AM
ANDERSON KERRII BDirectorJun 20, 2019 Option Exercise$77.193,100239,28922,233Jun 21, 2019, 03:26 PM
ANDERSON KERRII BDirectorJun 20, 2019 Sale$170.003,100527,00019,133Jun 21, 2019, 03:26 PM
EISENBERG GLENN AChief Financial Officer, EVPJun 07, 2019 Sale$167.4010,0001,673,97128,366Jun 11, 2019, 06:16 PM
Williams R SandersDirectorMay 06, 2019 Sale$162.2050081,1007,386May 08, 2019, 08:21 AM
MITTELSTAEDT ROBERT E JRDirectorMay 03, 2019 Option Exercise$64.423,700238,35418,909May 07, 2019, 11:00 AM
MITTELSTAEDT ROBERT E JRDirectorMay 03, 2019 Sale$166.303,700615,31015,209May 07, 2019, 11:00 AM
Uthgenannt Lisa JChief Human Resources OfficerMay 02, 2019 Sale$164.004,000656,0004,638May 06, 2019, 08:45 AM
Ratliff John DCEO, Covance Drug DevelopmentApr 03, 2019 Option Exercise$156.681,084169,84116,941Apr 05, 2019, 12:01 PM
KING DAVID PPresident & CEOApr 01, 2019 Option Exercise$154.7941,3116,394,529297,387Apr 03, 2019, 05:30 PM
EISENBERG GLENN AChief Financial Officer, EVPApr 01, 2019 Option Exercise$154.7910,0131,549,91232,622Apr 03, 2019, 05:29 PM
van der Vaart Sandra DSVP, Global General CounselApr 01, 2019 Option Exercise$154.791,782275,8364,656Apr 03, 2019, 05:27 PM
Dodson Edward TPrincipal Accounting OfficerApr 01, 2019 Option Exercise$154.791,779275,37113,663Apr 03, 2019, 05:24 PM
Uthgenannt Lisa JChief Human Resources OfficerApr 01, 2019 Option Exercise$154.793,236500,9008,638Apr 03, 2019, 05:20 PM
BERBERIAN LANCESVP, Chief Information OfficerApr 01, 2019 Option Exercise$154.792,287354,00511,999Apr 03, 2019, 05:18 PM
BELINGARD JEAN-LUCDirectorFeb 12, 2019 Option Exercise$146.5910415,24534,013Feb 14, 2019, 05:01 PM
BELINGARD JEAN-LUCDirectorFeb 12, 2019 Option Exercise$64.423,700238,35436,779Feb 14, 2019, 05:01 PM
BELINGARD JEAN-LUCDirectorFeb 12, 2019 Sale$146.063,700540,40733,079Feb 14, 2019, 05:01 PM
KING DAVID PPresident & CEOFeb 12, 2019 Option Exercise$146.591,571230,293246,281Feb 14, 2019, 04:44 PM
Williams R SandersDirectorFeb 13, 2019 Sale$147.001,038152,5867,886Feb 14, 2019, 04:18 PM
Dodson Edward TPrincipal Accounting OfficerFeb 12, 2019 Option Exercise$146.59547,9169,912Feb 14, 2019, 04:13 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 12, 2019 Option Exercise$146.59649,38228,823Feb 14, 2019, 04:10 PM
Ratliff John DCEO, Covance Drug DevelopmentFeb 12, 2019 Option Exercise$146.5965495,87015,601Feb 14, 2019, 04:08 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2019 Option Exercise$146.5923234,00920,235Feb 14, 2019, 04:05 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 12, 2019 Option Exercise$146.597010,2618,756Feb 14, 2019, 04:02 PM
Caveney Brian JSVP, Chief Medical OfficerFeb 12, 2019 Option Exercise$146.598212,020151Feb 14, 2019, 03:59 PM
Uthgenannt Lisa JChief Human Resources OfficerFeb 12, 2019 Option Exercise$146.5910315,0994,489Feb 14, 2019, 03:58 PM
Uthgenannt Lisa JChief Human Resources OfficerFeb 11, 2019 Option Exercise$144.2924034,6304,336Feb 13, 2019, 12:22 PM
Dodson Edward TPrincipal Accounting OfficerFeb 11, 2019 Option Exercise$144.2912417,8929,770Feb 13, 2019, 12:18 PM
KING DAVID PPresident & CEOFeb 11, 2019 Option Exercise$144.292,980429,984244,339Feb 13, 2019, 12:11 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 11, 2019 Option Exercise$144.2914320,63328,654Feb 13, 2019, 12:09 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 11, 2019 Option Exercise$144.291,449209,07619,687Feb 13, 2019, 12:05 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 11, 2019 Option Exercise$144.291,037149,6298,593Feb 13, 2019, 12:00 PM
Ratliff John DCEO, Covance Drug DevelopmentFeb 11, 2019 Option Exercise$144.291,973284,68414,792Feb 13, 2019, 11:55 AM
Ratliff John DCEO, Covance Drug DevelopmentFeb 07, 2019 Option Exercise$147.4655681,98810,665Feb 11, 2019, 07:59 PM
KING DAVID PPresident & CEOFeb 07, 2019 Option Exercise$147.461,254184,915239,775Feb 11, 2019, 07:56 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 07, 2019 Option Exercise$147.4629743,79616,259Feb 11, 2019, 07:53 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 07, 2019 Option Exercise$147.468212,09228,277Feb 11, 2019, 07:51 PM
Dodson Edward TPrincipal Accounting OfficerFeb 07, 2019 Option Exercise$147.466810,0279,444Feb 11, 2019, 07:48 PM
Uthgenannt Lisa JChief Human Resources OfficerFeb 07, 2019 Option Exercise$147.4614821,8243,972Feb 11, 2019, 07:46 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 07, 2019 Option Exercise$147.4610415,3366,133Feb 11, 2019, 07:44 PM
Williams R SandersDirectorNov 27, 2018 Sale$162.1435056,7497,886Nov 29, 2018, 10:00 AM
ANDERSON KERRII BDirectorNov 05, 2018 Option Exercise$64.423,700238,35421,795Nov 07, 2018, 10:54 AM
ANDERSON KERRII BDirectorNov 05, 2018 Sale$163.293,700604,16218,095Nov 07, 2018, 10:54 AM
Gary M. HuffCEO, LabCorp DiagnosticsSep 04, 2018 Option Exercise$169.156911,6711,850Sep 06, 2018, 10:21 AM
Dodson Edward TPrincipal Accounting OfficerJun 06, 2018 Option Exercise$84.8613,0001,103,18022,113Jun 08, 2018, 11:11 AM
Dodson Edward TPrincipal Accounting OfficerJun 06, 2018 Sale$183.3513,0002,383,5639,113Jun 08, 2018, 11:11 AM
Uthgenannt Lisa JChief Human Resources OfficerJun 04, 2018 Sale$182.104,500819,4503,755Jun 06, 2018, 02:59 PM
Gilliland Dwight GaryDirectorMay 31, 2018 Sale$181.291,263228,9674,637Jun 04, 2018, 04:17 PM
BERBERIAN LANCESVP, Chief Information OfficerMay 31, 2018 Sale$182.305,5001,002,6726,255Jun 04, 2018, 04:16 PM
Gary M. HuffCEO, LabCorp DiagnosticsMay 30, 2018 Sale$182.501,610293,8231,610Jun 01, 2018, 08:15 AM
EISENBERG GLENN AChief Financial Officer, EVPMay 30, 2018 Sale$181.2110,0001,812,06718,843Jun 01, 2018, 08:14 AM
KING DAVID PPresident & CEOMay 23, 2018 Option Exercise$84.8649,9664,240,115271,635May 25, 2018, 11:15 AM
KING DAVID PPresident & CEOMay 23, 2018 Sale$175.3749,9668,762,352227,069May 25, 2018, 11:15 AM
KING DAVID PPresident & CEOApr 23, 2018 Option Exercise$84.8649,9674,240,200271,636Apr 25, 2018, 04:59 PM
KING DAVID PPresident & CEOApr 23, 2018 Sale$166.1249,9678,300,692242,869Apr 25, 2018, 04:59 PM
Gary M. HuffCEO, LabCorp DiagnosticsApr 04, 2018 Option Exercise$163.841,376225,4443,220Apr 06, 2018, 09:39 AM
BERBERIAN LANCESVP, Chief Information OfficerMar 29, 2018 Option Exercise$161.752,121343,07211,440Apr 02, 2018, 11:54 AM
Dodson Edward TPrincipal Accounting OfficerMar 29, 2018 Option Exercise$161.751,600258,8009,113Apr 02, 2018, 11:53 AM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 29, 2018 Option Exercise$161.752,152348,08628,062Apr 02, 2018, 11:51 AM
EISENBERG GLENN AChief Financial Officer, EVPMar 29, 2018 Option Exercise$161.758,8501,431,48825,563Apr 02, 2018, 11:50 AM
KING DAVID PPresident & CEOMar 29, 2018 Option Exercise$161.7533,0155,340,176221,669Apr 02, 2018, 11:48 AM
Uthgenannt Lisa JChief Human Resources OfficerMar 29, 2018 Option Exercise$161.752,828457,4298,255Apr 02, 2018, 11:47 AM
KING DAVID PPresident & CEOMar 23, 2018 Option Exercise$84.8649,9674,240,200231,202Mar 27, 2018, 09:03 AM
KING DAVID PPresident & CEOMar 23, 2018 Sale$164.7549,9678,232,224229,513Mar 27, 2018, 09:03 AM
Dodson Edward TPrincipal Accounting OfficerMar 12, 2018 Option Exercise$175.6111119,4935,861Mar 14, 2018, 04:12 PM
KING DAVID PPresident & CEOMar 12, 2018 Option Exercise$175.612,732479,767181,235Mar 14, 2018, 03:47 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 12, 2018 Option Exercise$175.6112922,65424,619Mar 14, 2018, 03:38 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 12, 2018 Option Exercise$175.61732128,54714,726Mar 14, 2018, 03:33 PM
BERBERIAN LANCESVP, Chief Information OfficerMar 12, 2018 Option Exercise$175.6112021,0738,709Mar 14, 2018, 03:30 PM
Uthgenannt Lisa JChief Human Resources OfficerMar 12, 2018 Option Exercise$175.6118432,3124,590Mar 14, 2018, 03:28 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2018 Sale$167.368,4001,405,83915,931Feb 14, 2018, 02:32 PM
Ratliff John DCEO, Covance Drug DevelopmentFeb 09, 2018 Option Exercise$168.082,132358,3479,398Feb 13, 2018, 02:08 PM
ANDERSON KERRII BDirectorFeb 09, 2018 Option Exercise$75.633,300249,57921,395Feb 13, 2018, 01:58 PM
ANDERSON KERRII BDirectorFeb 09, 2018 Sale$166.103,300548,12318,095Feb 13, 2018, 01:58 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 09, 2018 Option Exercise$168.081,462245,73322,231Feb 13, 2018, 01:55 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 09, 2018 Option Exercise$168.081,048176,1488,429Feb 13, 2018, 01:54 PM
Dodson Edward TPrincipal Accounting OfficerFeb 09, 2018 Option Exercise$168.0816728,0695,506Feb 13, 2018, 01:51 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 09, 2018 Option Exercise$168.0814424,20424,284Feb 13, 2018, 01:47 PM
Uthgenannt Lisa JChief Human Resources OfficerFeb 09, 2018 Option Exercise$168.0820334,1204,237Feb 13, 2018, 01:46 PM
KING DAVID PPresident & CEOFeb 09, 2018 Option Exercise$168.083,138527,435177,890Feb 13, 2018, 01:44 PM
Uthgenannt Lisa JChief Human Resources OfficerFeb 07, 2018 Option Exercise$169.6612921,8863,837Feb 09, 2018, 04:16 PM
KING DAVID PPresident & CEOFeb 07, 2018 Option Exercise$169.661,264214,450173,485Feb 09, 2018, 04:13 PM
Ratliff John DCEO, Covance Drug DevelopmentFeb 07, 2018 Option Exercise$169.6656095,0105,430Feb 09, 2018, 04:11 PM
Gary M. HuffCEO, LabCorp DiagnosticsFeb 07, 2018 Option Exercise$169.6632955,8181,096Feb 09, 2018, 04:09 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 07, 2018 Option Exercise$169.6629950,72818,816Feb 09, 2018, 04:05 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 07, 2018 Option Exercise$169.668213,91223,908Feb 09, 2018, 04:02 PM
Dodson Edward TPrincipal Accounting OfficerFeb 07, 2018 Option Exercise$169.669215,6095,223Feb 09, 2018, 04:01 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 07, 2018 Option Exercise$169.6610517,8145,980Feb 09, 2018, 03:59 PM
Schechter Adam HDirectorFeb 08, 2018 Sale$169.291,263213,8136,034Feb 09, 2018, 03:56 PM
BELINGARD JEAN-LUCDirectorFeb 07, 2018 Option Exercise$169.6612721,54733,079Feb 09, 2018, 03:47 PM
Gilliland Dwight GaryDirectorOct 30, 2017 Sale$153.52971149,0683,501Nov 01, 2017, 10:31 AM
Gary M. HuffCEO, LabCorp DiagnosticsSep 01, 2017 Option Exercise$157.61518,038349Oct 23, 2017, 04:10 PM
KING DAVID PPresident & CEOSep 06, 2017 Option Exercise$90.7444,6874,054,898258,753Sep 07, 2017, 03:35 PM
KING DAVID PPresident & CEOSep 06, 2017 Sale$156.8644,6877,009,789221,566Sep 07, 2017, 03:35 PM
KING DAVID PPresident & CEOSep 05, 2017 Option Exercise$90.74132,71312,042,377346,779Sep 07, 2017, 09:18 AM
KING DAVID PPresident & CEOSep 05, 2017 Sale$157.06132,71320,843,373214,066Sep 07, 2017, 09:18 AM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryAug 25, 2017 Option Exercise$69.1231,5002,177,23955,194Aug 29, 2017, 02:26 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryAug 25, 2017 Sale$155.2231,5004,889,46123,694Aug 29, 2017, 02:26 PM
Williams R SandersDirectorAug 11, 2017 Option Exercise$77.193,100239,28910,073Aug 15, 2017, 03:03 PM
Williams R SandersDirectorAug 11, 2017 Sale$156.883,100486,3389,873Aug 15, 2017, 03:03 PM
Dodson Edward TPrincipal Accounting OfficerAug 01, 2017 Sale$160.132,871459,7407,702Aug 03, 2017, 04:35 PM
Uthgenannt Lisa JChief Human Resources OfficerAug 01, 2017 Sale$160.005,000800,0003,622Aug 03, 2017, 04:29 PM
EISENBERG GLENN AChief Financial Officer, EVPAug 01, 2017 Sale$159.465,968951,66918,122Aug 03, 2017, 04:22 PM
EISENBERG GLENN AChief Financial Officer, EVPJun 16, 2017 Option Exercise$140.771,926271,12324,090Jun 19, 2017, 02:48 PM
BERBERIAN LANCESVP, Chief Information OfficerMay 22, 2017 Sale$139.853,613505,2605,789May 24, 2017, 11:25 AM
BELINGARD JEAN-LUCDirectorMay 09, 2017 Option Exercise$77.5899276,95932,935May 11, 2017, 08:17 AM
BELINGARD JEAN-LUCDirectorMay 09, 2017 Sale$142.19992141,05231,943May 11, 2017, 08:17 AM
BERBERIAN LANCESVP, Chief Information OfficerMar 29, 2017 Option Exercise$143.193,142449,9039,402Mar 31, 2017, 01:50 PM
Dodson Edward TPrincipal Accounting OfficerMar 29, 2017 Option Exercise$143.192,850408,0927,754Mar 31, 2017, 01:49 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 29, 2017 Option Exercise$143.193,212459,92623,694Mar 31, 2017, 01:48 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 29, 2017 Option Exercise$143.199,7531,396,53221,966Mar 31, 2017, 01:47 PM
KING DAVID PPresident & CEOMar 29, 2017 Option Exercise$143.1948,5966,958,461198,359Mar 31, 2017, 01:45 PM
Uthgenannt Lisa JChief Human Resources OfficerMar 13, 2017 Option Exercise$144.243,654527,0538,803Mar 14, 2017, 03:17 PM
BERBERIAN LANCESVP, Chief Information OfficerMar 13, 2017 Option Exercise$144.2413219,0405,789Mar 14, 2017, 02:52 PM
Dodson Edward TPrincipal Accounting OfficerMar 13, 2017 Option Exercise$144.2414921,4923,849Mar 14, 2017, 02:44 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 13, 2017 Option Exercise$144.2415322,06919,136Mar 14, 2017, 02:43 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 13, 2017 Option Exercise$144.24774111,64211,209Mar 14, 2017, 02:41 PM
KING DAVID PPresident & CEOMar 13, 2017 Option Exercise$144.242,890416,854144,755Mar 14, 2017, 02:39 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 09, 2017 Sale$142.472,300327,69112,556Mar 13, 2017, 09:34 AM
MITTELSTAEDT ROBERT E JRDirectorFeb 24, 2017 Option Exercise$75.635,300400,83918,208Feb 27, 2017, 02:40 PM
MITTELSTAEDT ROBERT E JRDirectorFeb 24, 2017 Sale$142.695,300756,25618,008Feb 27, 2017, 02:40 PM
ANDERSON KERRII BDirectorFeb 24, 2017 Option Exercise$75.631,00075,63016,832Feb 27, 2017, 02:39 PM
ANDERSON KERRII BDirectorFeb 23, 2017 Option Exercise$76.601,992152,58916,832Feb 27, 2017, 02:39 PM
ANDERSON KERRII BDirectorFeb 23, 2017 Sale$140.001,992278,88015,832Feb 27, 2017, 02:39 PM
Dodson Edward TPrincipal Accounting OfficerFeb 13, 2017 Option Exercise$134.9318224,5573,598Feb 14, 2017, 05:45 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 13, 2017 Option Exercise$134.9320627,79618,826Feb 14, 2017, 05:45 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 13, 2017 Option Exercise$134.9355274,48112,656Feb 14, 2017, 05:42 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 13, 2017 Option Exercise$134.9348965,9815,703Feb 14, 2017, 05:42 PM
KING DAVID PPresident & CEOFeb 13, 2017 Option Exercise$134.933,968535,402141,568Feb 14, 2017, 05:42 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 13, 2017 Option Exercise$134.9348965,9815,703Feb 14, 2017, 05:40 PM
Uthgenannt Lisa JChief Human Resources OfficerFeb 09, 2017 Option Exercise$133.8324432,6554,039Feb 13, 2017, 02:40 PM
Dodson Edward TPrincipal Accounting OfficerFeb 09, 2017 Option Exercise$133.8313818,4693,230Feb 13, 2017, 02:31 PM
Ratliff John DCEO, Covance Drug DevelopmentFeb 09, 2017 Option Exercise$133.832,013269,4004,127Feb 13, 2017, 02:28 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 09, 2017 Option Exercise$133.8318825,16018,398Feb 13, 2017, 02:26 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 09, 2017 Option Exercise$133.831,610215,46611,534Feb 13, 2017, 02:24 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 09, 2017 Option Exercise$133.831,171156,7154,530Feb 13, 2017, 02:23 PM
KING DAVID PPresident & CEOFeb 09, 2017 Option Exercise$133.832,496334,040137,192Feb 13, 2017, 02:21 PM
BELINGARD JEAN-LUCDirectorFeb 09, 2017 Option Exercise$133.8315620,87731,943Feb 13, 2017, 01:53 PM
Uthgenannt Lisa JChief Human Resources OfficerAug 09, 2016 Sale$140.001,177164,7803,660Aug 11, 2016, 07:57 AM
EISENBERG GLENN AChief Financial Officer, EVPAug 04, 2016 Sale$140.108,0001,120,8048,668Aug 08, 2016, 02:58 PM
MITTELSTAEDT ROBERT E JRDirectorAug 04, 2016 Option Exercise$77.5899276,95912,340Aug 08, 2016, 02:55 PM
MITTELSTAEDT ROBERT E JRDirectorAug 04, 2016 Sale$140.15992139,02711,348Aug 08, 2016, 02:55 PM
EISENBERG GLENN AChief Financial Officer, EVPJun 16, 2016 Option Exercise$127.351,936246,55016,268Jun 20, 2016, 10:38 AM
KING DAVID PPresident & CEOJun 13, 2016 Option Exercise$70.15196,40013,777,460271,210Jun 15, 2016, 04:03 PM
KING DAVID PPresident & CEOJun 13, 2016 Sale$128.00196,40025,139,088197,755Jun 15, 2016, 04:03 PM
Uthgenannt Lisa JChief Human Resources OfficerApr 29, 2016 Sale$125.173,740468,1364,837May 13, 2016, 04:03 PM
Dodson Edward TPrincipal Accounting OfficerApr 27, 2016 Sale$126.429,3921,187,3372,717Apr 29, 2016, 09:01 AM
KING DAVID PPresident & CEOMar 30, 2016 Option Exercise$117.8548,4255,706,886147,371Apr 01, 2016, 01:22 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 30, 2016 Option Exercise$117.856,007707,92514,154Apr 01, 2016, 01:21 PM
Dodson Edward TPrincipal Accounting OfficerMar 30, 2016 Option Exercise$117.852,349276,83012,109Apr 01, 2016, 01:15 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 30, 2016 Option Exercise$117.852,466290,61822,285Apr 01, 2016, 01:12 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 31, 2016 Sale$116.854,219492,99018,066Apr 01, 2016, 01:12 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsMar 30, 2016 Option Exercise$117.8516,6051,956,89941,586Apr 01, 2016, 01:11 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsMar 31, 2016 Sale$116.8118,1322,118,03028,395Apr 01, 2016, 01:11 PM
BELINGARD JEAN-LUCDirectorMar 11, 2016 Option Exercise$115.4912414,32130,539Mar 15, 2016, 03:35 PM
BERBERIAN LANCESVP, Chief Information OfficerMar 11, 2016 Option Exercise$115.4913315,3602,205Mar 15, 2016, 01:45 PM
Dodson Edward TPrincipal Accounting OfficerMar 11, 2016 Option Exercise$115.4912414,3217,773Mar 15, 2016, 01:44 PM
EISENBERG GLENN AChief Financial Officer, EVPMar 11, 2016 Option Exercise$115.4977889,8517,596Mar 15, 2016, 01:42 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 11, 2016 Option Exercise$115.4915417,78518,375Mar 15, 2016, 01:41 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 14, 2016 Sale$115.3230935,63418,066Mar 15, 2016, 01:41 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsMar 11, 2016 Option Exercise$115.491,413163,18724,997Mar 15, 2016, 01:39 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsMar 14, 2016 Sale$115.321,543177,93923,454Mar 15, 2016, 01:39 PM
KING DAVID PPresident & CEOMar 11, 2016 Option Exercise$115.492,905335,49894,489Mar 15, 2016, 01:37 PM
Keller Deborah LCEO, Covance Drug DevelopmentMar 11, 2016 Option Exercise$115.494,587529,75319,754Mar 15, 2016, 01:36 PM
Uthgenannt Lisa JChief Human Resources OfficerMar 11, 2016 Option Exercise$115.493,379390,2418,577Mar 15, 2016, 01:34 PM
BELINGARD JEAN-LUCDirectorFeb 25, 2016 Option Exercise$59.371,29676,94430,722Feb 29, 2016, 01:52 PM
BELINGARD JEAN-LUCDirectorFeb 25, 2016 Sale$109.741,296142,22530,504Feb 29, 2016, 01:52 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsFeb 16, 2016 Sale$103.024,055417,74625,614Feb 18, 2016, 08:28 AM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 16, 2016 Sale$103.0237038,11718,066Feb 18, 2016, 08:27 AM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsFeb 12, 2016 Option Exercise$103.022,116217,99027,509Feb 16, 2016, 04:30 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsFeb 11, 2016 Option Exercise$101.401,345136,38326,166Feb 16, 2016, 04:30 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsFeb 12, 2016 Sale$101.672,712275,72923,454Feb 16, 2016, 04:30 PM
KING DAVID PPresident & CEOFeb 12, 2016 Option Exercise$103.023,735384,78091,318Feb 16, 2016, 04:25 PM
KING DAVID PPresident & CEOFeb 11, 2016 Option Exercise$101.402,768280,67586,783Feb 16, 2016, 04:25 PM
Dodson Edward TPrincipal Accounting OfficerFeb 12, 2016 Option Exercise$103.0218218,7507,497Feb 16, 2016, 04:24 PM
Dodson Edward TPrincipal Accounting OfficerFeb 11, 2016 Option Exercise$101.4021221,4977,132Feb 16, 2016, 04:24 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2016 Option Exercise$103.0251252,7466,748Feb 16, 2016, 04:23 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 11, 2016 Option Exercise$101.4055556,2775,720Feb 16, 2016, 04:23 PM
BERBERIAN LANCESVP, Chief Information OfficerFeb 11, 2016 Option Exercise$101.4051352,0181,938Feb 16, 2016, 04:22 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 11, 2016 Option Exercise$101.4022823,11918,471Feb 16, 2016, 04:21 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 12, 2016 Option Exercise$103.0217718,23518,436Feb 16, 2016, 04:21 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 12, 2016 Sale$101.6740541,17618,066Feb 16, 2016, 04:21 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryJan 08, 2016 Sale$119.051,215144,64618,066Jan 12, 2016, 04:51 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryDec 08, 2015 Sale$123.311,010124,54319,281Dec 10, 2015, 04:38 PM
Williams R SandersDirectorNov 02, 2015 Option Exercise$64.421,850119,1776,026Nov 04, 2015, 03:20 PM
Williams R SandersDirectorNov 02, 2015 Sale$124.301,850229,9495,076Nov 04, 2015, 03:20 PM
ANDERSON KERRII BDirectorOct 29, 2015 Option Exercise$59.371,29676,94413,035Nov 02, 2015, 02:31 PM
KING DAVID PPresident & CEOAug 03, 2015 Option Exercise$80.3750,0004,018,500131,153Aug 05, 2015, 03:53 PM
KING DAVID PPresident & CEOAug 03, 2015 Sale$127.9350,0006,396,35897,453Aug 05, 2015, 03:53 PM
HERRING JOSEPH LCEO of Covance Drug DivisionJul 31, 2015 Option Exercise$127.299,5861,220,20210,404Aug 04, 2015, 02:15 PM
KING DAVID PPresident & CEOJul 01, 2015 Option Exercise$80.3750,0004,018,500116,063Jul 06, 2015, 09:08 PM
KING DAVID PPresident & CEOJul 01, 2015 Sale$121.7850,0006,089,04095,553Jul 06, 2015, 09:08 PM
EISENBERG GLENN AChief Financial Officer, EVPJun 16, 2015 Option Exercise$120.481,596192,2864,602Jun 18, 2015, 04:07 PM
KING DAVID PPresident & CEOJun 01, 2015 Option Exercise$80.3750,0004,018,500115,899Jun 03, 2015, 04:17 PM
KING DAVID PPresident & CEOJun 01, 2015 Sale$118.5850,0005,928,845114,990Jun 03, 2015, 04:17 PM
MITTELSTAEDT ROBERT E JRDirectorMay 19, 2015 Option Exercise$59.371,29676,94411,407May 21, 2015, 01:30 PM
MITTELSTAEDT ROBERT E JRDirectorMay 19, 2015 Sale$119.021,296154,25411,007May 21, 2015, 01:30 PM
Williams R SandersDirectorMay 11, 2015 Sale$118.05965113,9144,678May 14, 2015, 10:58 AM
BELINGARD JEAN-LUCDirectorApr 29, 2015 Option Exercise$49.931,54276,99230,968May 01, 2015, 05:14 PM
BELINGARD JEAN-LUCDirectorApr 29, 2015 Sale$123.101,542189,82029,426May 01, 2015, 05:14 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsApr 23, 2015 Sale$126.561,394176,42524,648Apr 27, 2015, 05:28 PM
Brecher Mark ECMO, LabCorp DiagnosticsMar 30, 2015 Option Exercise$127.2817221,8926,936Apr 01, 2015, 08:35 PM
Brecher Mark ECMO, LabCorp DiagnosticsMar 30, 2015 Option Exercise$88.4119,2001,697,52026,136Apr 01, 2015, 08:35 PM
Brecher Mark ECMO, LabCorp DiagnosticsMar 31, 2015 Sale$127.0034744,0695,511Apr 01, 2015, 08:35 PM
Brecher Mark ECMO, LabCorp DiagnosticsMar 30, 2015 Sale$126.9820,2782,574,9215,858Apr 01, 2015, 08:35 PM
KING DAVID PPresident & CEOMar 30, 2015 Option Exercise$127.283,974505,81165,899Apr 01, 2015, 07:50 PM
Boyle James T. Jr.EVP,CEO of LabCorp DiagnosticsMar 30, 2015 Option Exercise$127.281,272161,90024,848Apr 01, 2015, 07:48 PM
Dodson Edward TPrincipal Accounting OfficerMar 30, 2015 Option Exercise$127.2817221,8926,575Apr 01, 2015, 07:46 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 30, 2015 Option Exercise$127.2817221,89220,291Apr 01, 2015, 07:44 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 02, 2015 Option Exercise$123.361,130139,39724,691Mar 04, 2015, 10:38 AM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 03, 2015 Sale$123.701,237153,01524,654Mar 04, 2015, 10:38 AM
Dodson Edward TPrincipal Accounting OfficerMar 02, 2015 Option Exercise$123.3615418,9976,228Mar 04, 2015, 10:37 AM
Brecher Mark EChief Medical OfficerMar 02, 2015 Option Exercise$123.3615418,9976,589Mar 04, 2015, 10:36 AM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 02, 2015 Option Exercise$123.3615519,12119,944Mar 04, 2015, 10:35 AM
KING DAVID PPresident & CEOMar 02, 2015 Option Exercise$123.363,515433,61061,543Mar 04, 2015, 10:33 AM
Williams R SandersDirectorFeb 26, 2015 Sale$123.962,267281,0256,441Mar 02, 2015, 04:26 PM
HERRING JOSEPH LCEO of Covance Drug DivisionFeb 25, 2015 Sale$121.6436,8764,485,4366,158Feb 27, 2015, 06:32 PM
Dodson Edward TPrincipal Accounting OfficerFeb 12, 2015 Option Exercise$116.8417820,7986,382Feb 17, 2015, 04:06 PM
KING DAVID PPresident & CEOFeb 12, 2015 Option Exercise$116.843,945460,93465,058Feb 17, 2015, 04:05 PM
Brecher Mark EChief Medical OfficerFeb 12, 2015 Option Exercise$116.8417720,6816,743Feb 17, 2015, 04:01 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 12, 2015 Option Exercise$116.8417820,79820,099Feb 17, 2015, 03:58 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 12, 2015 Option Exercise$116.8451059,5882,148Feb 17, 2015, 03:57 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 12, 2015 Option Exercise$116.842,287267,21329,704Feb 17, 2015, 03:55 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 12, 2015 Sale$116.712,714316,75125,821Feb 17, 2015, 03:55 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 13, 2015 Sale$116.663,883452,99127,807Feb 17, 2015, 03:55 PM
Dodson Edward TPrincipal Accounting OfficerFeb 11, 2015 Option Exercise$116.7321224,7476,013Feb 13, 2015, 05:44 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 11, 2015 Option Exercise$116.731,342156,65228,535Feb 13, 2015, 05:10 PM
Brecher Mark EChief Medical OfficerFeb 11, 2015 Option Exercise$116.7321324,8636,373Feb 13, 2015, 04:54 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 11, 2015 Option Exercise$116.7322826,61419,730Feb 13, 2015, 04:44 PM
EISENBERG GLENN AChief Financial Officer, EVPFeb 11, 2015 Option Exercise$116.7355564,7851,118Feb 13, 2015, 04:40 PM
KING DAVID PPresident & CEOFeb 11, 2015 Option Exercise$116.733,262380,77360,733Feb 13, 2015, 04:39 PM
BELINGARD JEAN-LUCDirectorFeb 10, 2015 Option Exercise$115.3915117,42429,426Feb 12, 2015, 04:07 PM
KING DAVID PPresident & CEOSep 22, 2014 Option Exercise$75.6365,2344,933,647120,817Sep 24, 2014, 11:44 AM
KING DAVID PPresident & CEOSep 22, 2014 Sale$104.7165,2346,830,74160,283Sep 24, 2014, 11:44 AM
Williams R SandersDirectorSep 05, 2014 Sale$107.952,000215,9066,505Sep 09, 2014, 03:35 PM
KING DAVID PPresident & CEOAug 22, 2014 Option Exercise$75.6365,2334,933,572120,816Aug 26, 2014, 02:38 PM
KING DAVID PPresident & CEOAug 22, 2014 Sale$106.1065,2336,921,48255,583Aug 26, 2014, 02:38 PM
KING DAVID PPresident & CEOJul 22, 2014 Option Exercise$75.6365,2334,933,572120,816Jul 24, 2014, 04:43 PM
KING DAVID PPresident & CEOJul 22, 2014 Sale$105.5565,2336,885,41157,183Jul 24, 2014, 04:43 PM
Boyle James T. Jr.EVP, Chief Operating OfficerJun 09, 2014 Option Exercise$84.8638,6003,275,59664,421Jun 10, 2014, 04:25 PM
Boyle James T. Jr.EVP, Chief Operating OfficerJun 09, 2014 Sale$103.0038,6003,975,80025,821Jun 10, 2014, 04:25 PM
Hayes William BChief Financial Officer, EVPJun 06, 2014 Option Exercise$88.3647,3674,185,38066,767Jun 10, 2014, 04:24 PM
Hayes William BChief Financial Officer, EVPJun 06, 2014 Sale$104.2347,3674,936,96541,500Jun 10, 2014, 04:24 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryJun 06, 2014 Option Exercise$60.0410,000600,40029,325Jun 10, 2014, 04:12 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryJun 06, 2014 Sale$104.3710,0001,043,70019,325Jun 10, 2014, 04:12 PM
Brecher Mark EChief Medical OfficerJun 04, 2014 Sale$102.312,600266,0065,754Jun 06, 2014, 02:53 PM
Williams R SandersDirectorMay 08, 2014 Option Exercise$98.961,593157,6437,905May 12, 2014, 05:11 PM
Rubenstein Arthur HDirectorMay 08, 2014 Option Exercise$98.961,593157,64311,772May 12, 2014, 05:10 PM
Schechter Adam HDirectorMay 08, 2014 Option Exercise$98.961,593157,6431,734May 12, 2014, 05:07 PM
NEUPERT PETER MDirectorMay 08, 2014 Option Exercise$98.961,593157,6432,168May 12, 2014, 05:05 PM
MITTELSTAEDT ROBERT E JRDirectorMay 08, 2014 Option Exercise$98.961,593157,6438,608May 12, 2014, 05:04 PM
LANE WENDY EDirectorMay 08, 2014 Option Exercise$98.961,593157,64318,988May 12, 2014, 05:03 PM
BELINGARD JEAN-LUCDirectorMay 08, 2014 Option Exercise$98.9616015,83428,074May 12, 2014, 05:00 PM
BELINGARD JEAN-LUCDirectorMay 08, 2014 Option Exercise$98.961,593157,64328,234May 12, 2014, 05:00 PM
ANDERSON KERRII BDirectorMay 08, 2014 Option Exercise$98.961,593157,64310,236May 12, 2014, 04:56 PM
WEIKEL M KEITHDirectorMay 08, 2014 Option Exercise$98.961,593157,64313,958May 09, 2014, 03:35 PM
WEIKEL M KEITHDirectorMay 07, 2014 Option Exercise$38.801,98476,97914,349May 09, 2014, 03:35 PM
WEIKEL M KEITHDirectorMay 07, 2014 Sale$98.281,984194,97913,248May 09, 2014, 03:35 PM
BELINGARD JEAN-LUCDirectorApr 30, 2014 Option Exercise$38.801,98476,97928,625May 02, 2014, 05:13 PM
BELINGARD JEAN-LUCDirectorApr 30, 2014 Sale$98.681,984195,78228,525May 02, 2014, 05:13 PM
Hayes William BChief Financial Officer, EVPApr 30, 2014 Sale$98.392,497245,68019,400May 02, 2014, 05:12 PM
LANE WENDY EDirectorApr 30, 2014 Option Exercise$38.8099238,49017,785May 02, 2014, 05:11 PM
LANE WENDY EDirectorApr 30, 2014 Sale$98.9739038,59917,395May 02, 2014, 05:11 PM
MITTELSTAEDT ROBERT E JRDirectorApr 30, 2014 Option Exercise$43.673,526153,9718,999May 02, 2014, 05:10 PM
MITTELSTAEDT ROBERT E JRDirectorApr 30, 2014 Sale$98.393,526346,9237,015May 02, 2014, 05:10 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 27, 2014 Option Exercise$97.872,304225,49228,342Mar 31, 2014, 03:55 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 28, 2014 Sale$98.362,521247,96625,821Mar 31, 2014, 03:55 PM
Brecher Mark EChief Medical OfficerMar 27, 2014 Option Exercise$97.8732932,1998,354Mar 31, 2014, 03:53 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 27, 2014 Option Exercise$97.8732932,19919,325Mar 31, 2014, 03:52 PM
Hayes William BChief Financial Officer, EVPMar 27, 2014 Option Exercise$97.872,283223,43721,897Mar 31, 2014, 03:51 PM
KING DAVID PPresident & CEOMar 27, 2014 Option Exercise$97.877,193703,97970,147Mar 31, 2014, 03:50 PM
Hayes William BChief Financial Officer, EVPMar 07, 2014 Option Exercise$84.8619,1661,626,42738,566Mar 10, 2014, 08:57 AM
Hayes William BChief Financial Officer, EVPMar 07, 2014 Sale$94.5019,1661,811,18719,400Mar 10, 2014, 08:57 AM
Hayes William BChief Financial Officer, EVPMar 06, 2014 Sale$94.004,682440,11923,802Mar 10, 2014, 08:57 AM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 03, 2014 Sale$93.061,582147,22125,821Mar 10, 2014, 08:54 AM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 28, 2014 Option Exercise$93.5478573,42927,403Mar 04, 2014, 02:00 PM
Brecher Mark EChief Medical OfficerFeb 28, 2014 Option Exercise$93.5415114,1257,691Mar 04, 2014, 01:58 PM
Hayes William BChief Financial Officer, EVPFeb 28, 2014 Option Exercise$93.5477472,40024,082Mar 04, 2014, 01:57 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 28, 2014 Option Exercise$93.5415114,12518,662Mar 04, 2014, 01:55 PM
KING DAVID PPresident & CEOFeb 28, 2014 Option Exercise$93.543,518329,07462,277Mar 04, 2014, 01:53 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 12, 2014 Option Exercise$90.982,046186,14532,311Feb 14, 2014, 07:29 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 13, 2014 Sale$90.294,123372,26630,416Feb 14, 2014, 07:29 PM
KING DAVID PPresident & CEOFeb 12, 2014 Option Exercise$90.983,949359,28065,795Feb 13, 2014, 07:39 PM
Brecher Mark EChief Medical OfficerFeb 12, 2014 Option Exercise$90.9819417,6507,842Feb 13, 2014, 07:36 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 12, 2014 Option Exercise$90.9818416,74018,813Feb 13, 2014, 07:34 PM
Hayes William BChief Financial Officer, EVPFeb 12, 2014 Option Exercise$90.9893484,97524,856Feb 13, 2014, 07:30 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 10, 2014 Option Exercise$91.3514212,97218,451Feb 12, 2014, 03:40 PM
Brecher Mark EChief Medical OfficerFeb 10, 2014 Option Exercise$91.3514212,9727,490Feb 12, 2014, 03:30 PM
Hayes William BChief Financial Officer, EVPFeb 10, 2014 Option Exercise$91.3560054,81022,974Feb 12, 2014, 03:28 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 10, 2014 Option Exercise$91.3559654,44529,392Feb 12, 2014, 03:27 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 11, 2014 Sale$91.151,204109,74528,188Feb 12, 2014, 03:27 PM
KING DAVID PPresident & CEOFeb 10, 2014 Option Exercise$91.352,225203,25461,474Feb 12, 2014, 03:22 PM
KING DAVID PPresident & CEOJan 27, 2014 Option Exercise$60.0424,2001,452,96887,899Jan 29, 2014, 03:18 PM
KING DAVID PPresident & CEOJan 27, 2014 Sale$90.1524,2002,181,63763,699Jan 29, 2014, 03:18 PM
KING DAVID PPresident & CEODec 24, 2013 Option Exercise$60.0425,0001,501,00088,628Dec 27, 2013, 04:50 PM
KING DAVID PPresident & CEODec 24, 2013 Sale$90.7925,0002,269,75063,628Dec 27, 2013, 04:50 PM
Brecher Mark EChief Medical OfficerNov 25, 2013 Sale$105.6240042,2487,585Nov 27, 2013, 10:59 AM
KING DAVID PPresident & CEONov 25, 2013 Option Exercise$60.0425,0001,501,00088,628Nov 27, 2013, 09:55 AM
KING DAVID PPresident & CEONov 25, 2013 Sale$106.0125,0002,650,30063,628Nov 27, 2013, 09:55 AM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryNov 11, 2013 Option Exercise$58.5710,000585,70028,593Nov 13, 2013, 01:54 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryNov 11, 2013 Sale$105.8310,0001,058,35018,593Nov 13, 2013, 01:54 PM
KING DAVID PPresident & CEOOct 24, 2013 Option Exercise$60.0425,0001,501,00088,628Oct 28, 2013, 09:14 AM
KING DAVID PPresident & CEOOct 24, 2013 Sale$100.9125,0002,522,80168,041Oct 28, 2013, 09:14 AM
Boyle James T. Jr.EVP, Chief Operating OfficerOct 17, 2013 Option Exercise$77.5724,4001,892,77244,388Oct 21, 2013, 02:59 PM
Boyle James T. Jr.EVP, Chief Operating OfficerOct 17, 2013 Sale$102.0024,4002,488,80029,988Oct 21, 2013, 02:59 PM
KING DAVID PPresident & CEOSep 25, 2013 Option Exercise$60.0425,0001,501,00088,628Sep 27, 2013, 10:45 AM
KING DAVID PPresident & CEOSep 25, 2013 Sale$99.0625,0002,476,61563,628Sep 27, 2013, 10:45 AM
KING DAVID PPresident & CEOAug 26, 2013 Option Exercise$60.0425,0001,501,00088,628Aug 28, 2013, 12:01 PM
KING DAVID PPresident & CEOAug 26, 2013 Sale$96.6025,0002,415,04763,628Aug 28, 2013, 12:01 PM
MITTELSTAEDT ROBERT E JRDirectorAug 21, 2013 Sale$96.867,429719,59214,244Aug 23, 2013, 10:09 AM
KING DAVID PPresident & CEOJul 24, 2013 Option Exercise$60.0425,0001,501,00088,628Jul 26, 2013, 03:56 PM
KING DAVID PPresident & CEOJul 24, 2013 Sale$97.7225,0002,442,89763,628Jul 26, 2013, 03:56 PM
KING DAVID PPresident & CEOJun 24, 2013 Option Exercise$60.0425,0001,501,00088,423Jun 26, 2013, 05:38 PM
KING DAVID PPresident & CEOJun 24, 2013 Sale$98.6625,0002,466,53364,123Jun 26, 2013, 05:38 PM
Boyle James T. Jr.EVP, Chief Operating OfficerJun 07, 2013 Option Exercise$70.1563,1004,426,46593,088Jun 11, 2013, 02:19 PM
Boyle James T. Jr.EVP, Chief Operating OfficerJun 07, 2013 Sale$99.6363,1006,286,65329,988Jun 11, 2013, 02:19 PM
Brecher Mark EChief Medical OfficerMay 28, 2013 Option Exercise$70.1514,9001,045,23524,653May 30, 2013, 04:34 PM
Brecher Mark EChief Medical OfficerMay 28, 2013 Sale$100.9216,9001,705,5487,753May 30, 2013, 04:34 PM
BELINGARD JEAN-LUCDirectorMay 24, 2013 Option Exercise$100.37606,02226,641May 29, 2013, 04:35 PM
Hayes William BChief Financial Officer, EVPMay 21, 2013 Option Exercise$77.68127,2009,880,83695,774May 23, 2013, 04:05 PM
Hayes William BChief Financial Officer, EVPMay 21, 2013 Sale$100.00127,20012,720,00023,574May 23, 2013, 04:05 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMay 17, 2013 Option Exercise$47.8910,000478,90028,593May 21, 2013, 05:26 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMay 17, 2013 Sale$98.4710,000984,70018,593May 21, 2013, 05:26 PM
BELINGARD JEAN-LUCDirectorMay 13, 2013 Option Exercise$95.01545,13126,701May 15, 2013, 05:03 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMay 10, 2013 Option Exercise$59.1360,7343,591,26198,896May 14, 2013, 04:37 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMay 10, 2013 Sale$93.8268,9086,464,86629,988May 14, 2013, 04:37 PM
BELINGARD JEAN-LUCDirectorMay 08, 2013 Option Exercise$30.362,53676,99329,291May 10, 2013, 07:56 AM
BELINGARD JEAN-LUCDirectorMay 08, 2013 Sale$92.882,536235,54426,755May 10, 2013, 07:56 AM
WEIKEL M KEITHDirectorMay 03, 2013 Option Exercise$31.352,04664,14214,411May 06, 2013, 12:35 PM
WEIKEL M KEITHDirectorMay 03, 2013 Sale$92.912,046190,08612,965May 06, 2013, 12:35 PM
LANE WENDY EDirectorApr 29, 2013 Option Exercise$93.7341238,61716,831May 01, 2013, 03:37 PM
LANE WENDY EDirectorApr 29, 2013 Option Exercise$30.361,26838,49617,205May 01, 2013, 03:37 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryApr 25, 2013 Sale$93.841,500140,76018,593Apr 29, 2013, 03:49 PM
Williams R SandersDirectorApr 24, 2013 Option Exercise$64.421,850119,1778,162Apr 25, 2013, 01:13 PM
Williams R SandersDirectorApr 24, 2013 Sale$93.771,850173,4776,932Apr 25, 2013, 01:13 PM
Hayes William BChief Financial Officer, EVPApr 11, 2013 Option Exercise$70.1522,2341,559,71545,808Apr 15, 2013, 03:37 PM
Hayes William BChief Financial Officer, EVPApr 11, 2013 Sale$95.0022,2342,112,23023,574Apr 15, 2013, 03:37 PM
KING DAVID PPresident & CEOMar 28, 2013 Option Exercise$90.2017,1801,549,63663,423Apr 01, 2013, 03:47 PM
Fonseca LidiaChief Information OfficerMar 28, 2013 Option Exercise$90.2087278,6549,087Apr 01, 2013, 03:45 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 28, 2013 Option Exercise$90.2087278,65420,093Apr 01, 2013, 03:44 PM
Hayes William BChief Financial Officer, EVPMar 28, 2013 Option Exercise$90.205,580503,31628,523Apr 01, 2013, 03:43 PM
Brecher Mark EChief Medical OfficerMar 28, 2013 Option Exercise$90.2090381,4519,753Apr 01, 2013, 03:41 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 28, 2013 Option Exercise$90.205,484494,65738,162Apr 01, 2013, 03:32 PM
KING DAVID PPresident & CEOFeb 28, 2013 Option Exercise$88.603,533313,02444,776Mar 04, 2013, 02:32 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 28, 2013 Option Exercise$88.6079069,99432,171Mar 04, 2013, 02:30 PM
Hayes William BChief Financial Officer, EVPFeb 28, 2013 Option Exercise$88.6077969,01921,974Mar 04, 2013, 02:29 PM
Brecher Mark EChief Medical OfficerFeb 28, 2013 Option Exercise$88.6015613,8227,951Mar 04, 2013, 02:27 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 28, 2013 Option Exercise$88.6015613,82218,353Mar 04, 2013, 02:26 PM
Fonseca LidiaChief Information OfficerFeb 28, 2013 Option Exercise$88.6015613,8227,347Mar 04, 2013, 02:24 PM
KING DAVID PPresident & CEOFeb 11, 2013 Option Exercise$90.064,115370,59750,292Feb 13, 2013, 05:17 PM
Brecher Mark EChief Medical OfficerFeb 11, 2013 Option Exercise$90.0632228,9998,235Feb 13, 2013, 05:15 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 11, 2013 Option Exercise$90.0631027,91918,638Feb 13, 2013, 05:10 PM
Fonseca LidiaChief Information OfficerFeb 11, 2013 Option Exercise$90.0631027,9197,632Feb 13, 2013, 05:06 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 11, 2013 Option Exercise$90.061,298116,89833,562Feb 13, 2013, 05:04 PM
Hayes William BChief Financial Officer, EVPFeb 11, 2013 Option Exercise$90.061,325119,32923,343Feb 13, 2013, 05:03 PM
MAC MAHON THOMAS PDirectorSep 06, 2012 Sale$89.7435,0003,141,04432,297Sep 10, 2012, 11:10 AM
MITTELSTAEDT ROBERT E JRDirectorAug 27, 2012 Option Exercise$30.362,53676,99316,980Aug 29, 2012, 03:01 PM
MITTELSTAEDT ROBERT E JRDirectorAug 27, 2012 Sale$88.612,536224,71514,444Aug 29, 2012, 03:01 PM
Brecher Mark EChief Medical OfficerJul 13, 2012 Option Exercise$60.0419,2001,152,76828,716Jul 17, 2012, 03:05 PM
Brecher Mark EChief Medical OfficerJul 13, 2012 Sale$95.0020,3411,932,3959,516Jul 17, 2012, 03:05 PM
Fonseca LidiaChief Information OfficerJul 13, 2012 Option Exercise$60.0418,2001,092,72826,013Jul 17, 2012, 03:02 PM
Fonseca LidiaChief Information OfficerJul 13, 2012 Sale$95.0018,2001,729,0007,813Jul 17, 2012, 03:02 PM
KING DAVID PPresident & CEOJul 09, 2012 Option Exercise$59.4384,8005,039,942195,032Jul 11, 2012, 02:54 PM
KING DAVID PPresident & CEOJul 09, 2012 Sale$92.1184,8007,810,928110,232Jul 11, 2012, 02:54 PM
Fonseca LidiaChief Information OfficerJun 27, 2012 Sale$90.001,687151,8307,813Jun 29, 2012, 03:36 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryJun 04, 2012 Sale$83.832,678224,50419,119Jun 06, 2012, 05:08 PM
BELINGARD JEAN-LUCDirectorMay 14, 2012 Option Exercise$85.33302,56024,955May 15, 2012, 01:41 PM
BELINGARD JEAN-LUCDirectorMay 11, 2012 Option Exercise$86.72242,08124,985May 15, 2012, 01:41 PM
LANE WENDY EDirectorMay 09, 2012 Option Exercise$48.0267732,51014,480May 11, 2012, 02:36 PM
LANE WENDY EDirectorMay 09, 2012 Sale$85.9851043,85114,470May 11, 2012, 02:36 PM
LANE WENDY EDirectorMay 08, 2012 Option Exercise$64.4261739,74714,587May 10, 2012, 09:37 AM
LANE WENDY EDirectorMay 08, 2012 Sale$86.4680069,17014,070May 10, 2012, 09:37 AM
BELINGARD JEAN-LUCDirectorMay 07, 2012 Option Exercise$87.04373,22025,009May 09, 2012, 10:46 AM
BELINGARD JEAN-LUCDirectorMay 01, 2012 Option Exercise$48.021,35364,97126,399May 03, 2012, 03:39 PM
BELINGARD JEAN-LUCDirectorMay 01, 2012 Sale$88.111,353119,21826,151May 03, 2012, 03:39 PM
Walton Andrew ScottEVPApr 09, 2012 Sale$91.824,000367,28024,298Apr 11, 2012, 02:57 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 26, 2012 Option Exercise$91.908,315764,14937,320Mar 28, 2012, 04:35 PM
KING DAVID PPresident & CEOMar 26, 2012 Option Exercise$91.9027,6902,544,711153,784Mar 28, 2012, 04:31 PM
Hayes William BChief Financial Officer, EVPMar 26, 2012 Option Exercise$91.9010,137931,59037,819Mar 28, 2012, 04:23 PM
Hayes William BChief Financial Officer, EVPMar 26, 2012 Option Exercise$70.152,750192,91326,828Mar 28, 2012, 04:23 PM
Hayes William BChief Financial Officer, EVPMar 27, 2012 Sale$91.6713,7411,259,58724,078Mar 28, 2012, 04:23 PM
Hayes William BChief Financial Officer, EVPMar 26, 2012 Sale$90.002,750247,50024,078Mar 28, 2012, 04:23 PM
Walton Andrew ScottEVPMar 26, 2012 Option Exercise$91.904,999459,40826,298Mar 28, 2012, 04:22 PM
Brecher Mark EChief Medical OfficerMar 26, 2012 Option Exercise$91.901,607147,6839,286Mar 28, 2012, 04:17 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 26, 2012 Option Exercise$91.901,559143,27221,497Mar 28, 2012, 04:16 PM
Fonseca LidiaChief Information OfficerMar 26, 2012 Option Exercise$91.901,559143,2729,500Mar 28, 2012, 04:15 PM
Hayes William BChief Financial Officer, EVPMar 23, 2012 Option Exercise$65.8972,0834,749,612100,648Mar 27, 2012, 03:58 PM
Hayes William BChief Financial Officer, EVPMar 23, 2012 Sale$89.6876,5706,866,83183,941Mar 27, 2012, 03:58 PM
MAC MAHON THOMAS PDirectorFeb 29, 2012 Sale$89.9860,0005,398,81265,497Mar 02, 2012, 03:26 PM
Walton Andrew ScottEVPFeb 10, 2012 Option Exercise$90.0346641,95417,221Feb 13, 2012, 03:38 PM
Walton Andrew ScottEVPFeb 09, 2012 Option Exercise$92.1172666,87218,001Feb 13, 2012, 03:38 PM
Hayes William BChief Financial Officer, EVPFeb 10, 2012 Option Exercise$90.0388879,94721,565Feb 13, 2012, 03:37 PM
Hayes William BChief Financial Officer, EVPFeb 09, 2012 Option Exercise$92.111,292119,00623,027Feb 13, 2012, 03:37 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 10, 2012 Option Exercise$90.0346641,95415,888Feb 13, 2012, 03:36 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 09, 2012 Option Exercise$92.111,268116,79516,939Feb 13, 2012, 03:36 PM
KING DAVID PPresident & CEOFeb 10, 2012 Option Exercise$90.033,170285,39594,146Feb 13, 2012, 03:36 PM
KING DAVID PPresident & CEOFeb 09, 2012 Option Exercise$92.114,721434,85199,679Feb 13, 2012, 03:36 PM
Fonseca LidiaChief Information OfficerFeb 10, 2012 Option Exercise$90.0317415,6654,855Feb 13, 2012, 03:34 PM
Fonseca LidiaChief Information OfficerFeb 09, 2012 Option Exercise$92.1129627,2655,153Feb 13, 2012, 03:34 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 10, 2012 Option Exercise$90.0317415,66517,072Feb 13, 2012, 03:34 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 09, 2012 Option Exercise$92.1129627,26517,370Feb 13, 2012, 03:34 PM
Brecher Mark EChief Medical OfficerFeb 09, 2012 Option Exercise$92.1175169,1755,294Feb 13, 2012, 03:33 PM
Brecher Mark EChief Medical OfficerFeb 10, 2012 Option Exercise$90.0318416,5664,543Feb 13, 2012, 03:33 PM
KING DAVID PPresident & CEOJan 25, 2012 Option Exercise$58.5720,0001,171,400122,037Jan 27, 2012, 04:09 PM
KING DAVID PPresident & CEOJan 25, 2012 Sale$92.0020,0001,840,000102,037Jan 27, 2012, 04:09 PM
KING DAVID PPresident & CEODec 02, 2011 Option Exercise$47.8920,000957,800121,957Dec 06, 2011, 02:57 PM
KING DAVID PPresident & CEODec 02, 2011 Sale$88.0020,0001,760,000101,957Dec 06, 2011, 02:57 PM
MITTELSTAEDT ROBERT E JRDirectorAug 18, 2011 Option Exercise$48.021,35364,97112,925Aug 22, 2011, 01:51 PM
MITTELSTAEDT ROBERT E JRDirectorAug 18, 2011 Sale$79.9681765,32912,108Aug 22, 2011, 01:51 PM
Williams R SandersDirectorMay 19, 2011 Option Exercise$75.946,292477,7989,812May 23, 2011, 01:01 PM
Williams R SandersDirectorMay 19, 2011 Sale$100.736,292633,7698,912May 23, 2011, 01:01 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMay 13, 2011 Option Exercise$78.7515,2001,196,97632,742May 17, 2011, 03:10 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMay 13, 2011 Sale$99.0415,2001,505,47917,542May 17, 2011, 03:10 PM
BELINGARD JEAN-LUCDirectorMay 12, 2011 Option Exercise$100.00303,00025,046May 13, 2011, 05:23 PM
BELINGARD JEAN-LUCDirectorMay 11, 2011 Option Exercise$34.251,89664,93826,272May 13, 2011, 05:23 PM
BELINGARD JEAN-LUCDirectorMay 11, 2011 Sale$98.791,896187,29825,172May 13, 2011, 05:23 PM
BELINGARD JEAN-LUCDirectorMay 09, 2011 Option Exercise$98.48302,95424,376May 10, 2011, 03:35 PM
BELINGARD JEAN-LUCDirectorMay 06, 2011 Option Exercise$97.59373,61124,406May 10, 2011, 03:35 PM
LANE WENDY EDirectorApr 25, 2011 Option Exercise$96.1033932,57913,453Apr 27, 2011, 04:04 PM
LANE WENDY EDirectorApr 25, 2011 Option Exercise$34.2594832,46913,792Apr 27, 2011, 04:04 PM
KING DAVID PPresident & CEOApr 25, 2011 Sale$95.867,254695,368101,765Apr 27, 2011, 04:03 PM
Brecher Mark EChief Medical OfficerApr 21, 2011 Sale$98.001,271124,5585,828Apr 22, 2011, 11:23 AM
MAC MAHON THOMAS PDirectorApr 15, 2011 Option Exercise$58.57103,8676,083,490208,664Apr 18, 2011, 03:10 PM
MAC MAHON THOMAS PDirectorApr 14, 2011 Option Exercise$58.5771,1334,166,260175,930Apr 18, 2011, 03:10 PM
MAC MAHON THOMAS PDirectorApr 15, 2011 Sale$95.9783,8678,048,482130,797Apr 18, 2011, 03:10 PM
MAC MAHON THOMAS PDirectorApr 14, 2011 Sale$95.0071,1336,757,855104,797Apr 18, 2011, 03:10 PM
Walton Andrew ScottEVPApr 14, 2011 Sale$95.001,535145,82518,413Apr 18, 2011, 03:08 PM
Walton Andrew ScottEVPApr 11, 2011 Sale$92.691,536142,37219,948Apr 13, 2011, 02:50 PM
Walton Andrew ScottEVPMar 30, 2011 Option Exercise$91.571,780162,99521,484Apr 01, 2011, 05:14 PM
Boyle James T. Jr.EVP, Chief Operating OfficerMar 30, 2011 Option Exercise$91.5778071,42517,622Apr 01, 2011, 05:13 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryMar 30, 2011 Option Exercise$91.5759754,66717,542Apr 01, 2011, 05:12 PM
Fonseca LidiaChief Information OfficerMar 30, 2011 Option Exercise$91.5759754,6675,325Apr 01, 2011, 05:11 PM
KING DAVID PPresident & CEOMar 30, 2011 Option Exercise$91.5710,702979,982109,019Apr 01, 2011, 05:09 PM
Hayes William BChief Financial Officer, EVPMar 30, 2011 Option Exercise$91.573,963362,89229,116Apr 01, 2011, 05:08 PM
Hayes William BChief Financial Officer, EVPMar 31, 2011 Sale$91.215,371489,86623,745Apr 01, 2011, 05:08 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 14, 2011 Option Exercise$87.7314112,37016,302Feb 16, 2011, 03:33 PM
Hayes William BChief Financial Officer, EVPFeb 14, 2011 Option Exercise$87.7389278,25524,953Feb 16, 2011, 03:30 PM
Hayes William BChief Financial Officer, EVPFeb 15, 2011 Sale$87.451,208105,64023,745Feb 16, 2011, 03:30 PM
Walton Andrew ScottEVPFeb 14, 2011 Option Exercise$87.7335731,32018,413Feb 16, 2011, 03:27 PM
KING DAVID PPresident & CEOFeb 14, 2011 Option Exercise$87.732,435213,62394,511Feb 16, 2011, 03:23 PM
Fonseca LidiaChief Information OfficerFeb 14, 2011 Option Exercise$87.7314112,3704,085Feb 16, 2011, 03:19 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 14, 2011 Option Exercise$87.7314112,37016,565Feb 16, 2011, 03:18 PM
Hayes William BChief Financial Officer, EVPFeb 11, 2011 Sale$87.181,846160,93425,845Feb 15, 2011, 12:08 PM
Hayes William BChief Financial Officer, EVPFeb 10, 2011 Option Exercise$87.7388777,81758,058Feb 11, 2011, 05:46 PM
Hayes William BChief Financial Officer, EVPFeb 09, 2011 Option Exercise$90.7471865,15124,726Feb 11, 2011, 05:46 PM
Hayes William BChief Financial Officer, EVPFeb 10, 2011 Option Exercise$60.0430,3671,823,23558,945Feb 11, 2011, 05:46 PM
Hayes William BChief Financial Officer, EVPFeb 10, 2011 Sale$88.1831,8152,805,42530,591Feb 11, 2011, 05:46 PM
KING DAVID PPresident & CEOFeb 10, 2011 Option Exercise$87.732,692236,16996,946Feb 11, 2011, 05:16 PM
KING DAVID PPresident & CEOFeb 09, 2011 Option Exercise$90.742,077188,46782,938Feb 11, 2011, 05:16 PM
Conrad Andrew JEVP, Chief Scientific OfficerFeb 10, 2011 Option Exercise$87.7351445,09326,541Feb 11, 2011, 05:13 PM
Conrad Andrew JEVP, Chief Scientific OfficerFeb 09, 2011 Option Exercise$90.7449645,00727,055Feb 11, 2011, 05:13 PM
Brecher Mark EChief Medical OfficerFeb 10, 2011 Option Exercise$87.7318416,1426,749Feb 11, 2011, 04:40 PM
Brecher Mark EChief Medical OfficerFeb 09, 2011 Option Exercise$90.741,07597,5452,624Feb 11, 2011, 04:40 PM
Walton Andrew ScottEVPFeb 10, 2011 Option Exercise$87.7346640,88218,770Feb 11, 2011, 04:40 PM
Walton Andrew ScottEVPFeb 09, 2011 Option Exercise$90.7441237,38516,336Feb 11, 2011, 04:40 PM
Fonseca LidiaChief Information OfficerFeb 09, 2011 Option Exercise$90.7417115,5173,304Feb 11, 2011, 04:36 PM
Fonseca LidiaChief Information OfficerFeb 10, 2011 Option Exercise$87.7317815,6164,226Feb 11, 2011, 04:36 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 10, 2011 Option Exercise$87.7346640,88216,706Feb 11, 2011, 04:30 PM
Boyle James T. Jr.EVP, Chief Operating OfficerFeb 09, 2011 Option Exercise$90.7468562,15711,772Feb 11, 2011, 04:30 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 09, 2011 Option Exercise$90.7417115,51715,521Feb 11, 2011, 04:28 PM
EBERTS F SAMUEL IIIChief Legal Officer, SecretaryFeb 10, 2011 Option Exercise$87.7317815,61616,443Feb 11, 2011, 04:28 PM
Hayes William BChief Financial Officer, EVPDec 27, 2010 Option Exercise$60.0430,3661,823,17555,810Dec 28, 2010, 02:04 PM
Hayes William BChief Financial Officer, EVPDec 27, 2010 Sale$87.9530,3662,670,70225,444Dec 28, 2010, 02:04 PM
MAC MAHON THOMAS PDirectorDec 01, 2010 Option Exercise$47.89175,0008,380,750259,797Dec 03, 2010, 09:21 AM
MAC MAHON THOMAS PDirectorDec 01, 2010 Sale$85.00155,00013,175,000104,797Dec 03, 2010, 09:21 AM
Walton Andrew ScottEVPOct 29, 2010 Sale$81.0088171,36116,748Nov 02, 2010, 05:16 PM
Walton Andrew ScottEVPOct 29, 2010 Sale$81.0088171,36116,748Nov 02, 2010, 05:16 PM
Walton Andrew ScottEVPOct 29, 2010 Sale$81.0088171,36116,748Nov 02, 2010, 08:27 AM
Walton Andrew ScottEVPOct 29, 2010 Sale$81.0088171,36116,748Nov 02, 2010, 08:27 AM
Hayes William BChief Financial Officer, EVPOct 13, 2010 Option Exercise$58.5730,0001,757,10055,444Oct 15, 2010, 02:45 PM
Hayes William BChief Financial Officer, EVPOct 13, 2010 Sale$80.0030,0002,400,00025,444Oct 15, 2010, 02:45 PM
Walton Andrew ScottEVPOct 06, 2010 Option Exercise$58.575,000292,85022,629Oct 08, 2010, 04:15 PM
Walton Andrew ScottEVPOct 06, 2010 Sale$79.505,000397,50017,629Oct 08, 2010, 04:15 PM
Walton Andrew ScottEVPOct 01, 2010 Sale$79.0088169,59917,629Oct 05, 2010, 04:54 PM
Walton Andrew ScottEVPOct 01, 2010 Sale$79.0088169,59917,629Oct 05, 2010, 04:54 PM
MITTELSTAEDT ROBERT E JRDirectorSep 08, 2010 Option Exercise$34.251,89664,93813,304Sep 10, 2010, 10:31 AM
MITTELSTAEDT ROBERT E JRDirectorSep 08, 2010 Sale$74.321,896140,90613,204Sep 10, 2010, 10:31 AM
Conrad Andrew JEVP, Chief Scientific OfficerJul 26, 2010 Buy$74.326,100453,3476,100Jul 30, 2010, 11:07 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
van der Vaart Sandra DEVP, Chief Legal Officer05/14/2024421,655
ANDERSON KERRII BDirector04/30/202451,034
ANDERSON KERRII BDirector05/02/202450,025
EISENBERG GLENN AChief Financial Officer, EVP04/30/2024905,359
Wilkinson Peter JSVP, Chief Accounting Officer04/29/2024498,358
EISENBERG GLENN AChief Financial Officer, EVP04/15/2024914,127
Schroeder Mark SEVP, Pres Diagnostics & COO04/01/20241,407,387
Summy Amy B.EVP, Chief Marketing Officer04/01/2024760,515
Bailey Megan D.EVP, Chief Strategy Officer04/01/202414,928
van der Vaart Sandra DEVP, Chief Legal Officer03/27/2024564,165
van der Vaart Sandra DEVP, Chief Legal Officer03/28/2024770,077
Caveney Brian JEVP, Pres of ED, CMO & CSO03/27/20241,096,061
Schroeder Mark SEVP, Pres Diagnostics & COO03/27/20241,099,959
Schechter Adam HPresident and CEO03/27/20246,886,710
DiVincenzo Jonathan P.EVP, Pres, Central Labs & Intl03/27/2024206,175
Wilkinson Peter JSVP, Chief Accounting Officer03/27/2024193,614
Summy Amy B.EVP, Chief Marketing Officer03/27/2024468,224
EISENBERG GLENN AChief Financial Officer, EVP03/27/20241,906,899
BERBERIAN LANCEEVP, CIO & CTO03/27/2024714,464
Schroeder Mark SEVP, Pres Diagnostics & COO03/07/2024248,114
Schroeder Mark SEVP, Pres Diagnostics & COO03/07/20241,102,736
Summy Amy B.EVP, Chief Marketing Officer03/07/202449,588
EISENBERG GLENN AChief Financial Officer, EVP02/21/20242,299,656
EISENBERG GLENN AChief Financial Officer, EVP02/21/20247,451,867
DiVincenzo Jonathan P.EVP, Pres, Central Labs & Intl02/21/2024107,745
van der Vaart Sandra DEVP, Chief Legal Officer02/13/202453,669
Schechter Adam HPresident & CEO02/12/2024279,991
EISENBERG GLENN AChief Financial Officer, EVP02/12/202448,902
DiVincenzo Jonathan P.EVP, Pres, Central Labs & Intl02/12/202413,420
Caveney Brian JEVP, Pres of ED, CMO & CSO02/12/202431,161
BERBERIAN LANCEEVP, CIO & CTO02/12/202419,788
Schroeder Mark SEVP, Pres Diagnostics & COO02/12/202428,659
Summy Amy B.EVP, Chief Marketing Officer02/12/202415,012
van der Vaart Sandra DEVP, Chief Legal Officer02/12/202419,788
Wilkinson Peter JSVP, Chief Accounting Officer02/12/20249,780
van der Vaart Sandra DEVP, Chief Legal Officer02/08/202457,514
Schechter Adam HPresident & CEO02/07/2024257,043
EISENBERG GLENN AChief Financial Officer, EVP02/07/202452,796
DiVincenzo Jonathan P.EVP, Pres, Central Labs & Intl02/07/202426,621
Caveney Brian JEVP, Pres of ED, CMO & CSO02/07/202445,637
BERBERIAN LANCEEVP, CIO & CTO02/07/202421,029
Bailey Megan D.EVP, Chief Strategy Officer02/07/202425,279
GRAHAM ANITA ZEVP, CHRO02/07/202423,937
Schroeder Mark SEVP, Pres Diagnostics & COO02/07/202440,715
Summy Amy B.EVP, Chief Marketing Officer02/07/202416,331
van der Vaart Sandra DEVP, Chief Legal Officer02/07/202421,029
Wilkinson Peter JSVP, Chief Accounting Officer02/07/202410,291
BELINGARD JEAN-LUCDirector02/07/202421,252
Wilkinson Peter JSVP, Chief Accounting Officer02/02/20249,969
Summy Amy B.EVP, Chief Marketing Officer02/02/202417,723
BERBERIAN LANCEEVP, CIO & CTO02/02/202419,717
Caveney Brian JEVP, Pres of ED, CMO & CSO02/02/202436,776
Schechter Adam HPresident & CEO02/02/2024182,106
DiVincenzo Jonathan P.EVP, Pres, Central Labs & Intl02/02/202418,831
EISENBERG GLENN AChief Financial Officer, EVP02/02/202450,511
Schroeder Mark SEVP, Pres Diagnostics & COO02/02/202429,243
van der Vaart Sandra DEVP, Chief Legal Officer02/02/202415,729
van der Vaart Sandra DEVP, Chief Legal Officer02/05/202442,570
DiVincenzo Jonathan P.EVP, Pres, Central Labs & Intl12/15/20234,171
Wilkinson Peter JSVP, Chief Accounting Officer11/16/2023291,627
ANDERSON KERRII BDirector08/08/20231,057,832
Wilkinson Peter JSVP, Chief Accounting Officer08/01/20233,631
van der Vaart Sandra DEVP, Chief Legal Officer06/29/202350,880
Kirchgraber Paul RCEO, Covance Drug Development05/19/2023784,793
Kirchgraber Paul RCEO, Covance Drug Development05/19/2023932,707
Schroeder Mark SEVP, Pres Diagnostics & COO05/18/2023195,900
Schroeder Mark SEVP, Pres Diagnostics & COO05/18/2023325,155
Schechter Adam HPresident & CEO03/30/20234,189,756
Kirchgraber Paul RCEO, Covance Drug Development03/30/2023648,484
EISENBERG GLENN AChief Financial Officer, EVP03/30/20231,163,721
Caveney Brian JEVP, President of Diagnostics03/30/2023671,853
BERBERIAN LANCEEVP, CIO & CTO03/30/2023404,235
Schroeder Mark SEVP, President-Diagnostics Lab03/30/2023643,990
Schroeder Mark SEVP, President-Diagnostics Lab03/31/2023879,982
Seltz Judith CEVP, CHRO03/30/2023261,551
Summy Amy B.EVP, Chief Marketing Officer03/30/2023285,144
van der Vaart Sandra DEVP, Chief Legal Officer03/30/2023308,064
Wilkinson Peter JSVP, Chief Accounting Officer03/30/2023118,192
Summy Amy B.EVP, Chief Marketing Officer03/02/202389,558
Kirchgraber Paul RCEO, Covance Drug Development02/21/2023547,530
Kirchgraber Paul RCEO, Covance Drug Development02/21/20232,004,675
Schroeder Mark SEVP, President-Diagnostics Lab02/14/202376,518
BELINGARD JEAN-LUCDirector02/13/202318,610
BERBERIAN LANCEEVP, CIO & CTO02/13/202321,091
Caveney Brian JEVP, President of Diagnostics02/13/202330,768
Kirchgraber Paul RCEO, Covance Drug Development02/13/202335,234
EISENBERG GLENN AChief Financial Officer, EVP02/13/202348,385
Schechter Adam HPresident & CEO02/13/2023290,312
Schroeder Mark SEVP, President-Diagnostics Lab02/13/202328,287
Seltz Judith CEVP, CHRO02/13/202317,121
Summy Amy B.EVP, Chief Marketing Officer02/13/202313,399
van der Vaart Sandra DEVP, Chief Legal Officer02/13/202319,354
Wilkinson Peter JSVP, Chief Accounting Officer02/13/20239,429
van der Vaart Sandra DEVP, Chief Legal Officer02/07/202353,219
Schroeder Mark SEVP, President-Diagnostics Lab02/07/202399,391
Schechter Adam HPresident & CEO02/06/2023334,476
Caveney Brian JEVP, President of Diagnostics02/06/202340,098
BERBERIAN LANCEEVP, CIO & CTO02/06/202326,406
EISENBERG GLENN AChief Financial Officer, EVP02/06/202363,815
Kirchgraber Paul RCEO, Covance Drug Development02/06/202340,098
Schroeder Mark SEVP, President-Diagnostics Lab02/06/202336,920
Seltz Judith CEVP, CHRO02/06/202320,538
Summy Amy B.EVP, Chief Marketing Officer02/06/202320,294
van der Vaart Sandra DEVP, Chief Legal Officer02/06/202319,805
Wilkinson Peter JSVP, Chief Accounting Officer02/06/202312,714
Seltz Judith CEVP, CHRO02/02/202319,634
van der Vaart Sandra DEVP, Chief Legal Officer02/02/202316,319
van der Vaart Sandra DEVP, Chief Legal Officer02/03/202343,925
Wilkinson Peter JSVP, Chief Accounting Officer02/02/202310,455
Summy Amy B.EVP, Chief Marketing Officer02/02/202319,634
Schroeder Mark SEVP, President-Diagnostics Lab02/02/202330,344
Schroeder Mark SEVP, President-Diagnostics Lab02/03/202382,264
Schechter Adam HPresident & CEO02/02/2023205,267
Kirchgraber Paul RCEO, Covance Drug Development02/02/202335,954
EISENBERG GLENN AChief Financial Officer, EVP02/02/202352,528
Caveney Brian JEVP, President of Diagnostics02/02/202336,719
BERBERIAN LANCEEVP, CIO & CTO02/02/202326,009
Schroeder Mark SEVP, President-Diagnostics Lab11/08/2022259,660
Schroeder Mark SEVP, President-Diagnostics Lab11/07/2022208,990
Caveney Brian JEVP, President of Diagnostics11/07/2022208,990
EISENBERG GLENN AChief Financial Officer, EVP11/01/20221,190,251
Schechter Adam HPresident & CEO11/01/2022198,746
Kirchgraber Paul RCEO, Covance Drug Development11/01/2022198,524
EISENBERG GLENN AChief Financial Officer, EVP09/26/20225,265,581
Caveney Brian JEVP, President of Diagnostics09/07/202210,173
EISENBERG GLENN AChief Financial Officer, EVP08/03/20224,722,543
EISENBERG GLENN AChief Financial Officer, EVP08/03/20228,151,450
Wilkinson Peter JSVP, Chief Accounting Officer08/01/20225,933
Wilkinson Peter JSVP, Chief Accounting Officer08/01/2022112,435
Wilkinson Peter JSVP, Chief Accounting Officer08/01/2022665,634
Caveney Brian JEVP, President of Diagnostics06/07/202210,172
Schroeder Mark SEVP, President-Diagnostics Lab03/29/2022652,871
van der Vaart Sandra DEVP, Chief Legal Officer03/29/2022678,642
BERBERIAN LANCEEVP, CIO & CTO03/28/2022652,351
Caveney Brian JEVP, President of Diagnostics03/28/2022520,499
EISENBERG GLENN AChief Financial Officer, EVP03/28/20221,737,576
Kirchgraber Paul RCEO, Covance Drug Development03/28/2022455,540
Schroeder Mark SEVP, President-Diagnostics Lab03/28/2022521,052
van der Vaart Sandra DEVP, Chief Legal Officer03/28/2022495,345
Wilkinson Peter JSVP, Chief Accounting Officer03/28/2022252,924
Williams R SandersDirector03/25/2022156,145
Summy Amy B.EVP, Chief Marketing Officer03/10/202265,290
NEUPERT PETER MDirector02/16/2022922,815
Schroeder Mark SEVP, President-Diagnostics Lab02/15/202256,714
van der Vaart Sandra DEVP, Chief Legal Officer02/15/202256,714
Wilkinson Peter JSVP, Chief Accounting Officer02/14/202271,169
Caveney Brian JEVP, President of Diagnostics02/14/2022212,145
EISENBERG GLENN AChief Financial Officer, EVP02/14/202275,532
Kirchgraber Paul RCEO, Covance Drug Development02/14/202229,449
BERBERIAN LANCEEVP, CIO & CTO02/14/2022217,871
Schroeder Mark SEVP, President-Diagnostics Lab02/14/202220,996
van der Vaart Sandra DEVP, Chief Legal Officer02/14/202220,996
BERBERIAN LANCEEVP, CIO & CTO02/04/202230,245
Caveney Brian JEVP, President of Diagnostics02/04/202245,784
EISENBERG GLENN AChief Financial Officer, EVP02/04/202279,359
Kirchgraber Paul RCEO, Covance Drug Development02/04/202245,784
Schechter Adam HPresident & CEO02/04/2022391,802
Schroeder Mark SEVP, President-Diagnostics Lab02/04/202242,177
Schroeder Mark SEVP, President-Diagnostics Lab02/07/202256,586
Seltz Judith CEVP, CHRO02/04/202223,586
Summy Amy B.EVP, Chief Marketing Officer02/04/202223,031
van der Vaart Sandra DEVP, Chief Legal Officer02/04/202222,753
van der Vaart Sandra DEVP, Chief Legal Officer02/07/202260,469
Wilkinson Peter JSVP, Chief Accounting Officer02/04/202214,706
Schroeder Mark SEVP, President-Diagnostics Lab02/02/202233,055
Schroeder Mark SEVP, President-Diagnostics Lab02/03/202243,761
van der Vaart Sandra DEVP, Chief Legal Officer02/02/202217,484
van der Vaart Sandra DEVP, Chief Legal Officer02/03/202246,751
Summy Amy B.EVP, Chief Marketing Officer02/02/202221,035
Kirchgraber Paul RCEO, Covance Drug Development02/02/202239,338
Seltz Judith CEVP, CHRO02/02/202220,762
Wilkinson Peter JSVP, Chief Accounting Officer02/02/202211,200
Caveney Brian JEVP, President of Diagnostics02/02/202240,157
Schechter Adam HPresident & CEO02/02/2022219,364
EISENBERG GLENN AChief Financial Officer, EVP02/02/202264,470
BERBERIAN LANCEEVP, CIO & CTO02/02/202228,138
BELINGARD JEAN-LUCDirector02/02/202221,308
Gilliland Dwight GaryDirector12/15/2021151,128
Caveney Brian JEVP, President of Diagnostics11/05/2021247,081
Schroeder Mark SEVP, President-Diagnostics Lab11/05/2021247,081
Schechter Adam HPresident & CEO11/01/2021255,859
EISENBERG GLENN AChief Financial Officer, EVP11/01/20211,164,939
Kirchgraber Paul RCEO, Covance Drug Development11/01/2021259,324
van der Vaart Sandra DEVP, Chief Legal Officer09/15/2021381,870
van der Vaart Sandra DEVP, Chief Legal Officer09/15/20211,335,510
Wilkinson Peter JSVP, Chief Accounting Officer08/02/20214,464
van der Vaart Sandra DEVP, Chief Legal Officer06/07/2021381,870
van der Vaart Sandra DEVP, Chief Legal Officer06/07/20211,199,520
BELINGARD JEAN-LUCDirector05/03/2021256,074
BELINGARD JEAN-LUCDirector05/03/2021699,803
Kirchgraber Paul RCEO, Covance Drug Development04/03/2021114,207
Schroeder Mark SEVP, President-Diagnostics Lab03/30/2021168,004
van der Vaart Sandra DEVP, Chief Legal Officer03/30/2021204,527
EISENBERG GLENN AChief Financial Officer, EVP03/27/2021904,430
BERBERIAN LANCEEVP, CIO & CTO03/27/2021271,455
Caveney Brian JEVP, President of Diagnostics03/27/2021271,455
Kirchgraber Paul RCEO, Covance Drug Development03/27/2021198,748
Schroeder Mark SEVP, President-Diagnostics Lab03/27/2021271,455
van der Vaart Sandra DEVP, Chief Legal Officer03/27/2021172,835
Wilkinson Peter JSVP, Chief Accounting Officer02/12/202162,662
Wilkinson Peter JSVP, Chief Accounting Officer02/18/2021340,251
Wilkinson Peter JSVP, Chief Accounting Officer02/18/2021559,590
van der Vaart Sandra DEVP, Chief Legal Officer02/12/202137,645
van der Vaart Sandra DEVP, Chief Legal Officer02/16/202149,202
Schroeder Mark SEVP, President-Diagnostics Lab02/12/202133,833
Schroeder Mark SEVP, President-Diagnostics Lab02/16/202144,567
Kirchgraber Paul RCEO, Covance Drug Development02/12/202142,887
EISENBERG GLENN AChief Financial Officer, EVP02/12/2021121,989
Caveney Brian JEVP, President of Diagnostics02/12/2021203,474
BERBERIAN LANCEEVP, CIO & CTO02/12/2021208,001
Schechter Adam HPresident & CEO02/04/2021230,046
Wilkinson Peter JSVP, Chief Accounting Officer02/04/202111,860
van der Vaart Sandra DEVP, Chief Legal Officer02/04/202118,574
van der Vaart Sandra DEVP, Chief Legal Officer02/05/202124,618
Summy Amy B.EVP, Chief Marketing Officer02/04/202121,035
Schroeder Mark SEVP, President-Diagnostics Lab02/04/202134,462
Schroeder Mark SEVP, President-Diagnostics Lab02/05/202145,848
Kirchgraber Paul RCEO, Covance Drug Development02/04/202141,847
EISENBERG GLENN AChief Financial Officer, EVP02/04/202168,477
Caveney Brian JEVP, President of Diagnostics02/04/202142,518
BERBERIAN LANCEEVP, CIO & CTO02/04/202129,315
Seltz Judith CEVP, CHRO02/04/202121,483
BELINGARD JEAN-LUCDirector02/04/202122,154
Williams R SandersDirector01/26/2021128,037
Schroeder Mark SEVP, President-Diagnostics Lab11/06/2020126,179
Caveney Brian JEVP, President of Diagnostics11/05/2020189,976
Schroeder Mark SEVP, President-Diagnostics Lab11/05/2020179,041
Kirchgraber Paul RCEO, Covance Drug Development11/04/2020321,204
EISENBERG GLENN AChief Financial Officer, EVP11/02/2020835,966
Schechter Adam HPresident & CEO11/02/2020183,399
Kirchgraber Paul RCEO, Covance Drug Development11/02/2020185,471
Caveney Brian JEVP, President of Diagnostics09/25/202052,306
Williams R SandersDirector07/08/2020128,037
Williams R SandersDirector07/08/2020225,056
van der Vaart Sandra DEVP, Chief Legal Officer07/02/202073,950
van der Vaart Sandra DEVP, Chief Legal Officer06/24/2020139,808
KING DAVID PDirector05/05/20205,000,000
Seltz Judith CEVP, CHRO03/10/202055,625
Seltz Judith CEVP, CHRO02/28/202043,735
Kirchgraber Paul RCEO, Covance Drug Development04/03/202042,151
KING DAVID PDirector03/30/20203,243,727
van der Vaart Sandra DEVP, Chief Legal Officer03/30/2020145,937
EISENBERG GLENN AChief Financial Officer, EVP03/30/2020763,595
Kirchgraber Paul RCEO, Covance Drug Development03/30/2020133,797
Schroeder Mark SEVP, President-Diagnostics Lab03/30/2020152,138
BERBERIAN LANCEEVP, CIO & CTO03/30/2020223,655
Wilkinson Peter JSVP, Chief Accounting Officer02/21/202056,326
BELINGARD JEAN-LUCDirector02/19/2020239,289
BELINGARD JEAN-LUCDirector02/19/20205,024,761
EISENBERG GLENN AChief Financial Officer, EVP02/12/202096,005
van der Vaart Sandra DSVP, Global General Counsel02/12/202029,627
van der Vaart Sandra DSVP, Global General Counsel02/13/202039,206
Schroeder Mark SEVP, President-Diagnostics Lab02/12/202026,626
Schroeder Mark SEVP, President-Diagnostics Lab02/13/202035,436
BERBERIAN LANCESVP, Chief Information Officer02/12/2020163,509
Caveney Brian JEVP, President of Diagnostics02/12/2020162,384
Wilkinson Peter JSVP, Chief Accounting Officer02/12/202051,003
Kirchgraber Paul RCEO, Covance Drug Development02/12/202029,814
KING DAVID PDirector02/12/2020615,033
BELINGARD JEAN-LUCDirector02/12/202023,064
Williams R SandersDirector02/13/2020231,277
Schroeder Mark SEVP, President-Diagnostics Lab02/07/202014,951
Schroeder Mark SEVP, President-Diagnostics Lab02/10/202019,655
van der Vaart Sandra DSVP, Global General Counsel02/07/202018,415
van der Vaart Sandra DSVP, Global General Counsel02/10/202024,205
Kirchgraber Paul RCEO, Covance Drug Development02/07/202018,780
KING DAVID PDirector02/07/2020228,277
EISENBERG GLENN AChief Financial Officer, EVP02/07/202053,787
BERBERIAN LANCESVP, Chief Information Officer02/07/202018,780
BELINGARD JEAN-LUCDirector12/04/201956,185
KING DAVID PPresident & CEO10/28/20194,991,216
ANDERSON KERRII BDirector09/23/2019256,074
ANDERSON KERRII BDirector09/23/2019446,810
Uthgenannt Lisa JChief Human Resources Officer09/04/2019322,060
Uthgenannt Lisa JChief Human Resources Officer09/04/2019415,743
BERBERIAN LANCESVP, Chief Information Officer08/30/20191,002,171
Williams R SandersDirector08/05/201981,455
EISENBERG GLENN AChief Financial Officer, EVP07/08/2019983,260
van der Vaart Sandra DSVP, Global General Counsel07/08/2019411,474
ANDERSON KERRII BDirector06/20/2019239,289
ANDERSON KERRII BDirector06/20/2019527,000
EISENBERG GLENN AChief Financial Officer, EVP06/07/20191,673,971
Williams R SandersDirector05/06/201981,100
MITTELSTAEDT ROBERT E JRDirector05/03/2019238,354
MITTELSTAEDT ROBERT E JRDirector05/03/2019615,310
Uthgenannt Lisa JChief Human Resources Officer05/02/2019656,000
Ratliff John DCEO, Covance Drug Development04/03/2019169,841
KING DAVID PPresident & CEO04/01/20196,394,529
EISENBERG GLENN AChief Financial Officer, EVP04/01/20191,549,912
van der Vaart Sandra DSVP, Global General Counsel04/01/2019275,836
Dodson Edward TPrincipal Accounting Officer04/01/2019275,371
Uthgenannt Lisa JChief Human Resources Officer04/01/2019500,900
BERBERIAN LANCESVP, Chief Information Officer04/01/2019354,005
BELINGARD JEAN-LUCDirector02/12/201915,245
BELINGARD JEAN-LUCDirector02/12/2019238,354
BELINGARD JEAN-LUCDirector02/12/2019540,407
KING DAVID PPresident & CEO02/12/2019230,293
Williams R SandersDirector02/13/2019152,586
Dodson Edward TPrincipal Accounting Officer02/12/20197,916
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/12/20199,382
Ratliff John DCEO, Covance Drug Development02/12/201995,870
EISENBERG GLENN AChief Financial Officer, EVP02/12/201934,009
BERBERIAN LANCESVP, Chief Information Officer02/12/201910,261
Caveney Brian JSVP, Chief Medical Officer02/12/201912,020
Uthgenannt Lisa JChief Human Resources Officer02/12/201915,099
Uthgenannt Lisa JChief Human Resources Officer02/11/201934,630
Dodson Edward TPrincipal Accounting Officer02/11/201917,892
KING DAVID PPresident & CEO02/11/2019429,984
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/11/201920,633
EISENBERG GLENN AChief Financial Officer, EVP02/11/2019209,076
BERBERIAN LANCESVP, Chief Information Officer02/11/2019149,629
Ratliff John DCEO, Covance Drug Development02/11/2019284,684
Ratliff John DCEO, Covance Drug Development02/07/201981,988
KING DAVID PPresident & CEO02/07/2019184,915
EISENBERG GLENN AChief Financial Officer, EVP02/07/201943,796
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/07/201912,092
Dodson Edward TPrincipal Accounting Officer02/07/201910,027
Uthgenannt Lisa JChief Human Resources Officer02/07/201921,824
BERBERIAN LANCESVP, Chief Information Officer02/07/201915,336
Williams R SandersDirector11/27/201856,749
ANDERSON KERRII BDirector11/05/2018238,354
ANDERSON KERRII BDirector11/05/2018604,162
Gary M. HuffCEO, LabCorp Diagnostics09/04/201811,671
Dodson Edward TPrincipal Accounting Officer06/06/20181,103,180
Dodson Edward TPrincipal Accounting Officer06/06/20182,383,563
Uthgenannt Lisa JChief Human Resources Officer06/04/2018819,450
Gilliland Dwight GaryDirector05/31/2018228,967
BERBERIAN LANCESVP, Chief Information Officer05/31/20181,002,672
Gary M. HuffCEO, LabCorp Diagnostics05/30/2018293,823
EISENBERG GLENN AChief Financial Officer, EVP05/30/20181,812,067
KING DAVID PPresident & CEO05/23/20184,240,115
KING DAVID PPresident & CEO05/23/20188,762,352
KING DAVID PPresident & CEO04/23/20184,240,200
KING DAVID PPresident & CEO04/23/20188,300,692
Gary M. HuffCEO, LabCorp Diagnostics04/04/2018225,444
BERBERIAN LANCESVP, Chief Information Officer03/29/2018343,072
Dodson Edward TPrincipal Accounting Officer03/29/2018258,800
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/29/2018348,086
EISENBERG GLENN AChief Financial Officer, EVP03/29/20181,431,488
KING DAVID PPresident & CEO03/29/20185,340,176
Uthgenannt Lisa JChief Human Resources Officer03/29/2018457,429
KING DAVID PPresident & CEO03/23/20184,240,200
KING DAVID PPresident & CEO03/23/20188,232,224
Dodson Edward TPrincipal Accounting Officer03/12/201819,493
KING DAVID PPresident & CEO03/12/2018479,767
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/12/201822,654
EISENBERG GLENN AChief Financial Officer, EVP03/12/2018128,547
BERBERIAN LANCESVP, Chief Information Officer03/12/201821,073
Uthgenannt Lisa JChief Human Resources Officer03/12/201832,312
EISENBERG GLENN AChief Financial Officer, EVP02/12/20181,405,839
Ratliff John DCEO, Covance Drug Development02/09/2018358,347
ANDERSON KERRII BDirector02/09/2018249,579
ANDERSON KERRII BDirector02/09/2018548,123
EISENBERG GLENN AChief Financial Officer, EVP02/09/2018245,733
BERBERIAN LANCESVP, Chief Information Officer02/09/2018176,148
Dodson Edward TPrincipal Accounting Officer02/09/201828,069
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/09/201824,204
Uthgenannt Lisa JChief Human Resources Officer02/09/201834,120
KING DAVID PPresident & CEO02/09/2018527,435
Uthgenannt Lisa JChief Human Resources Officer02/07/201821,886
KING DAVID PPresident & CEO02/07/2018214,450
Ratliff John DCEO, Covance Drug Development02/07/201895,010
Gary M. HuffCEO, LabCorp Diagnostics02/07/201855,818
EISENBERG GLENN AChief Financial Officer, EVP02/07/201850,728
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/07/201813,912
Dodson Edward TPrincipal Accounting Officer02/07/201815,609
BERBERIAN LANCESVP, Chief Information Officer02/07/201817,814
Schechter Adam HDirector02/08/2018213,813
BELINGARD JEAN-LUCDirector02/07/201821,547
Gilliland Dwight GaryDirector10/30/2017149,068
Gary M. HuffCEO, LabCorp Diagnostics09/01/20178,038
KING DAVID PPresident & CEO09/06/20174,054,898
KING DAVID PPresident & CEO09/06/20177,009,789
KING DAVID PPresident & CEO09/05/201712,042,377
KING DAVID PPresident & CEO09/05/201720,843,373
EBERTS F SAMUEL IIIChief Legal Officer, Secretary08/25/20172,177,239
EBERTS F SAMUEL IIIChief Legal Officer, Secretary08/25/20174,889,461
Williams R SandersDirector08/11/2017239,289
Williams R SandersDirector08/11/2017486,338
Dodson Edward TPrincipal Accounting Officer08/01/2017459,740
Uthgenannt Lisa JChief Human Resources Officer08/01/2017800,000
EISENBERG GLENN AChief Financial Officer, EVP08/01/2017951,669
EISENBERG GLENN AChief Financial Officer, EVP06/16/2017271,123
BERBERIAN LANCESVP, Chief Information Officer05/22/2017505,260
BELINGARD JEAN-LUCDirector05/09/201776,959
BELINGARD JEAN-LUCDirector05/09/2017141,052
BERBERIAN LANCESVP, Chief Information Officer03/29/2017449,903
Dodson Edward TPrincipal Accounting Officer03/29/2017408,092
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/29/2017459,926
EISENBERG GLENN AChief Financial Officer, EVP03/29/20171,396,532
KING DAVID PPresident & CEO03/29/20176,958,461
Uthgenannt Lisa JChief Human Resources Officer03/13/2017527,053
BERBERIAN LANCESVP, Chief Information Officer03/13/201719,040
Dodson Edward TPrincipal Accounting Officer03/13/201721,492
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/13/201722,069
EISENBERG GLENN AChief Financial Officer, EVP03/13/2017111,642
KING DAVID PPresident & CEO03/13/2017416,854
EISENBERG GLENN AChief Financial Officer, EVP03/09/2017327,691
MITTELSTAEDT ROBERT E JRDirector02/24/2017400,839
MITTELSTAEDT ROBERT E JRDirector02/24/2017756,256
ANDERSON KERRII BDirector02/24/201775,630
ANDERSON KERRII BDirector02/23/2017152,589
ANDERSON KERRII BDirector02/23/2017278,880
Dodson Edward TPrincipal Accounting Officer02/13/201724,557
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/13/201727,796
EISENBERG GLENN AChief Financial Officer, EVP02/13/201774,481
BERBERIAN LANCESVP, Chief Information Officer02/13/201765,981
KING DAVID PPresident & CEO02/13/2017535,402
BERBERIAN LANCESVP, Chief Information Officer02/13/201765,981
Uthgenannt Lisa JChief Human Resources Officer02/09/201732,655
Dodson Edward TPrincipal Accounting Officer02/09/201718,469
Ratliff John DCEO, Covance Drug Development02/09/2017269,400
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/09/201725,160
EISENBERG GLENN AChief Financial Officer, EVP02/09/2017215,466
BERBERIAN LANCESVP, Chief Information Officer02/09/2017156,715
KING DAVID PPresident & CEO02/09/2017334,040
BELINGARD JEAN-LUCDirector02/09/201720,877
Uthgenannt Lisa JChief Human Resources Officer08/09/2016164,780
EISENBERG GLENN AChief Financial Officer, EVP08/04/20161,120,804
MITTELSTAEDT ROBERT E JRDirector08/04/201676,959
MITTELSTAEDT ROBERT E JRDirector08/04/2016139,027
EISENBERG GLENN AChief Financial Officer, EVP06/16/2016246,550
KING DAVID PPresident & CEO06/13/201613,777,460
KING DAVID PPresident & CEO06/13/201625,139,088
Uthgenannt Lisa JChief Human Resources Officer04/29/2016468,136
Dodson Edward TPrincipal Accounting Officer04/27/20161,187,337
KING DAVID PPresident & CEO03/30/20165,706,886
EISENBERG GLENN AChief Financial Officer, EVP03/30/2016707,925
Dodson Edward TPrincipal Accounting Officer03/30/2016276,830
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/30/2016290,618
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/31/2016492,990
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics03/30/20161,956,899
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics03/31/20162,118,030
BELINGARD JEAN-LUCDirector03/11/201614,321
BERBERIAN LANCESVP, Chief Information Officer03/11/201615,360
Dodson Edward TPrincipal Accounting Officer03/11/201614,321
EISENBERG GLENN AChief Financial Officer, EVP03/11/201689,851
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/11/201617,785
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/14/201635,634
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics03/11/2016163,187
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics03/14/2016177,939
KING DAVID PPresident & CEO03/11/2016335,498
Keller Deborah LCEO, Covance Drug Development03/11/2016529,753
Uthgenannt Lisa JChief Human Resources Officer03/11/2016390,241
BELINGARD JEAN-LUCDirector02/25/201676,944
BELINGARD JEAN-LUCDirector02/25/2016142,225
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics02/16/2016417,746
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/16/201638,117
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics02/12/2016217,990
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics02/11/2016136,383
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics02/12/2016275,729
KING DAVID PPresident & CEO02/12/2016384,780
KING DAVID PPresident & CEO02/11/2016280,675
Dodson Edward TPrincipal Accounting Officer02/12/201618,750
Dodson Edward TPrincipal Accounting Officer02/11/201621,497
EISENBERG GLENN AChief Financial Officer, EVP02/12/201652,746
EISENBERG GLENN AChief Financial Officer, EVP02/11/201656,277
BERBERIAN LANCESVP, Chief Information Officer02/11/201652,018
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/11/201623,119
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/12/201618,235
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/12/201641,176
EBERTS F SAMUEL IIIChief Legal Officer, Secretary01/08/2016144,646
EBERTS F SAMUEL IIIChief Legal Officer, Secretary12/08/2015124,543
Williams R SandersDirector11/02/2015119,177
Williams R SandersDirector11/02/2015229,949
ANDERSON KERRII BDirector10/29/201576,944
KING DAVID PPresident & CEO08/03/20154,018,500
KING DAVID PPresident & CEO08/03/20156,396,358
HERRING JOSEPH LCEO of Covance Drug Division07/31/20151,220,202
KING DAVID PPresident & CEO07/01/20154,018,500
KING DAVID PPresident & CEO07/01/20156,089,040
EISENBERG GLENN AChief Financial Officer, EVP06/16/2015192,286
KING DAVID PPresident & CEO06/01/20154,018,500
KING DAVID PPresident & CEO06/01/20155,928,845
MITTELSTAEDT ROBERT E JRDirector05/19/201576,944
MITTELSTAEDT ROBERT E JRDirector05/19/2015154,254
Williams R SandersDirector05/11/2015113,914
BELINGARD JEAN-LUCDirector04/29/201576,992
BELINGARD JEAN-LUCDirector04/29/2015189,820
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics04/23/2015176,425
Brecher Mark ECMO, LabCorp Diagnostics03/30/201521,892
Brecher Mark ECMO, LabCorp Diagnostics03/30/20151,697,520
Brecher Mark ECMO, LabCorp Diagnostics03/31/201544,069
Brecher Mark ECMO, LabCorp Diagnostics03/30/20152,574,921
KING DAVID PPresident & CEO03/30/2015505,811
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics03/30/2015161,900
Dodson Edward TPrincipal Accounting Officer03/30/201521,892
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/30/201521,892
Boyle James T. Jr.EVP, Chief Operating Officer03/02/2015139,397
Boyle James T. Jr.EVP, Chief Operating Officer03/03/2015153,015
Dodson Edward TPrincipal Accounting Officer03/02/201518,997
Brecher Mark EChief Medical Officer03/02/201518,997
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/02/201519,121
KING DAVID PPresident & CEO03/02/2015433,610
Williams R SandersDirector02/26/2015281,025
HERRING JOSEPH LCEO of Covance Drug Division02/25/20154,485,436
Dodson Edward TPrincipal Accounting Officer02/12/201520,798
KING DAVID PPresident & CEO02/12/2015460,934
Brecher Mark EChief Medical Officer02/12/201520,681
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/12/201520,798
EISENBERG GLENN AChief Financial Officer, EVP02/12/201559,588
Boyle James T. Jr.EVP, Chief Operating Officer02/12/2015267,213
Boyle James T. Jr.EVP, Chief Operating Officer02/12/2015316,751
Boyle James T. Jr.EVP, Chief Operating Officer02/13/2015452,991
Dodson Edward TPrincipal Accounting Officer02/11/201524,747
Boyle James T. Jr.EVP, Chief Operating Officer02/11/2015156,652
Brecher Mark EChief Medical Officer02/11/201524,863
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/11/201526,614
EISENBERG GLENN AChief Financial Officer, EVP02/11/201564,785
KING DAVID PPresident & CEO02/11/2015380,773
BELINGARD JEAN-LUCDirector02/10/201517,424
KING DAVID PPresident & CEO09/22/20144,933,647
KING DAVID PPresident & CEO09/22/20146,830,741
Williams R SandersDirector09/05/2014215,906
KING DAVID PPresident & CEO08/22/20144,933,572
KING DAVID PPresident & CEO08/22/20146,921,482
KING DAVID PPresident & CEO07/22/20144,933,572
KING DAVID PPresident & CEO07/22/20146,885,411
Boyle James T. Jr.EVP, Chief Operating Officer06/09/20143,275,596
Boyle James T. Jr.EVP, Chief Operating Officer06/09/20143,975,800
Hayes William BChief Financial Officer, EVP06/06/20144,185,380
Hayes William BChief Financial Officer, EVP06/06/20144,936,965
EBERTS F SAMUEL IIIChief Legal Officer, Secretary06/06/2014600,400
EBERTS F SAMUEL IIIChief Legal Officer, Secretary06/06/20141,043,700
Brecher Mark EChief Medical Officer06/04/2014266,006
Williams R SandersDirector05/08/2014157,643
Rubenstein Arthur HDirector05/08/2014157,643
Schechter Adam HDirector05/08/2014157,643
NEUPERT PETER MDirector05/08/2014157,643
MITTELSTAEDT ROBERT E JRDirector05/08/2014157,643
LANE WENDY EDirector05/08/2014157,643
BELINGARD JEAN-LUCDirector05/08/201415,834
BELINGARD JEAN-LUCDirector05/08/2014157,643
ANDERSON KERRII BDirector05/08/2014157,643
WEIKEL M KEITHDirector05/08/2014157,643
WEIKEL M KEITHDirector05/07/201476,979
WEIKEL M KEITHDirector05/07/2014194,979
BELINGARD JEAN-LUCDirector04/30/201476,979
BELINGARD JEAN-LUCDirector04/30/2014195,782
Hayes William BChief Financial Officer, EVP04/30/2014245,680
LANE WENDY EDirector04/30/201438,490
LANE WENDY EDirector04/30/201438,599
MITTELSTAEDT ROBERT E JRDirector04/30/2014153,971
MITTELSTAEDT ROBERT E JRDirector04/30/2014346,923
Boyle James T. Jr.EVP, Chief Operating Officer03/27/2014225,492
Boyle James T. Jr.EVP, Chief Operating Officer03/28/2014247,966
Brecher Mark EChief Medical Officer03/27/201432,199
EBERTS F SAMUEL IIIChief Legal Officer, Secretary03/27/201432,199
Hayes William BChief Financial Officer, EVP03/27/2014223,437
KING DAVID PPresident & CEO03/27/2014703,979
Hayes William BChief Financial Officer, EVP03/07/20141,626,427
Hayes William BChief Financial Officer, EVP03/07/20141,811,187
Hayes William BChief Financial Officer, EVP03/06/2014440,119
Boyle James T. Jr.EVP, Chief Operating Officer03/03/2014147,221
Boyle James T. Jr.EVP, Chief Operating Officer02/28/201473,429
Brecher Mark EChief Medical Officer02/28/201414,125
Hayes William BChief Financial Officer, EVP02/28/201472,400
EBERTS F SAMUEL IIIChief Legal Officer, Secretary02/28/201414,125
KING DAVID PPresident & CEO02/28/2014329,074
Boyle James T. Jr.EVP, Chief Operating Officer02/12/2014